Thyroid Hormone Receptor Nucleocytoplasmic Transport by Jibo, Zhang
W&M ScholarWorks 
Dissertations, Theses, and Masters Projects Theses, Dissertations, & Master Projects 
2016 
Thyroid Hormone Receptor Nucleocytoplasmic Transport 
Zhang Jibo 
College of William and Mary, jzhang10@email.wm.edu 
Follow this and additional works at: https://scholarworks.wm.edu/etd 
 Part of the Biology Commons 
Recommended Citation 
Jibo, Zhang, "Thyroid Hormone Receptor Nucleocytoplasmic Transport" (2016). Dissertations, Theses, 
and Masters Projects. Paper 1477068484. 
http://doi.org/10.21220/S2W305 
This Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M 
ScholarWorks. It has been accepted for inclusion in Dissertations, Theses, and Masters Projects by an authorized 
administrator of W&M ScholarWorks. For more information, please contact scholarworks@wm.edu. 
 
 
Thyroid Hormone Receptor Nucleocytoplasmic Transport 
 
 
 
Jibo Zhang 
Williamsburg, VA 
 
 
Bachelor of Science, Department of Biology 
Florida Institute of Technology, 2013 
 
A Thesis Presented to the Graduate Faculty 
of the College of William and Mary in Candidacy for the Degree of 
 
Master of Science 
 
 
Department of Biology 
 
 
 
The College of William and Mary 
August, 2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by Jibo Zhang. 2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMPLIANCE PAGE 
 
 
                    Research approved by:  
 
 
                                             Institutional Biosafety Committee 
 
 
 
                   Protocol number: IBC-2014-01-10-9227-laalli 
 
                   Date(s) of approval: 01-30-2014 
                                                   01-30-2015 
                                                   01-30-2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
The thyroid hormone receptor α1 (TRα1) and the thyroid hormone receptor β1 (TRβ1) 
are transcription factors that modulate the expression of target genes that are important 
in metabolism and development in response to thyroid hormone. Although primarily 
localized to the nucleus, prior studies have shown that TRα1 and TRβ1 shuttle rapidly 
between the nucleus and cytoplasm, and that nuclear import of TR1 is directed by two 
nuclear localization signal (NLS) motifs: NLS-1 in the hinge domain, and NLS-2 in the 
N-terminal A/B domain. In contrast, TR1 lacks NLS-2. Previous studies also 
characterized two nuclear export signal (NES) motifs, NES-H3/H6 and NES-H12, that 
reside in the ligand-binding domain and mediate TR nuclear export. Here, we 
investigated which importins mediate nuclear import of TR1 using a combined 
approach of shRNA-mediated knockdown and coimmunoprecipitation assays in HeLa 
(human) cells. Among all the importins we tested in transient transfection assays 
(importins 4, 5, 6, 7, 8, 9, 13, importin β1, and adaptor importin α variants), only importin 
7, importin β1, and adaptor importin α1 knockdown experiments resulted in a significant 
localization pattern change from primarily nuclear to a more cytosolic distribution of 
TRα1. To demonstrate direct interaction between TRα1 or TRβ1 and the importins, 
“GFP-trap” co-immunoprecipitation assays were performed. Importin 7, importin β1, and 
adaptor importin α1 were shown to interact with TRα1, while importin 4 as a negative 
control, did not. Our data show that nuclear entry of TR1 in HeLa cells is facilitated by 
both importin 7, likely through interactions with NLS-2, and importin 1 and the adapter 
importin 1 interacting with NLS-1 and NLS-2. In contrast, TR1 nuclear import is 
facilitated only by importin 1/1 interacting with NLS-1. Prior results from knockdown 
and overexpression studies provided evidence that multiple exportins influence TR 
localization. Here, we investigated which exportins serve as a direct carrier for each of 
the multiple NES motifs in TR1, using GFP-trap assays. Consistent with our prior 
studies, results show protein-protein interactions between TRα1 and exportin4, 
exportin5, and exportin7, but not with exportin6. Taken together, our findings highlight a 
fine balance of nuclear import, retention, and export that modulates TR function. 
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Chapter 1: General Introduction 
Thyroid hormones (THs) affect a wide variety of tissues, and have major influences 
on metabolic efficiency, thermogenesis and energy expenditure (Yeshuda-Shnaidman et 
al., 2013). THs also play a role in the development of muscles, liver tissue, brain tissue, 
and others (Chavez et al., 1998). It is safe to say that every single cell in our body is, or 
has been, influenced by THs.  
Thyroid hormone regulates gene expression by binding with the thyroid hormone 
receptor (TR), a ligand-dependent transcription factor. TR is expressed as different 
variants (TRα1, TRα2, TRα3, TRβ1, TRβ2, TRβ3) in different tissues (Schapira et al., 
2003). These variants are closely related to each other. TRα1, TRα3 and TRα3 are the 
results of alternative splicing of TRα mRNA which is encoded on chromosome 17. TRβ1, 
TRβ2 and TRβ3, on the other hand, are encoded by a separate gene on chromosome 3, 
and result from alternative promoter usage (Wood et al., 1994). Each isoform can form 
either homodimers or heterodimers with retinoid X receptors on thyroid hormone 
response elements (TREs) to repress gene expression when TH is absent. When cells 
are exposed to TH, TRs (except for TRα2 which does not bind ligand) bind with TH, and 
promote gene expression by recruiting coactivators. Unlike steroid hormone receptors 
which are sequestered in the cytosol and translocate to the nucleus in response to ligand, 
TRs are primarily nuclear localized both in the presence and absence of ligand. An 
interesting phenomenon, discovered by Bunn et al. (2001) is that TRα1 shuttles between 
the nucleus and the cytoplasm. Since the molecular weight of TRα1 is about 46 kD, which 
is larger than the limit for diffusion through the nuclear pore complexes (NPCs), the 
process of TRα1 crossing the nuclear envelope must be mediated by transport factors, 
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called karyopherins (Steward, 2007). Karyopherins that transport proteins into the 
nucleus are called importins, while those that transport proteins back to the cytoplasm 
are called exportins.  
The National Center for Biotechnology Information (NCBI) indicates that more than 
18 importins and 6 exportins are encoded in the human genome (Okada et al., 2008). 
Each of them overlaps in function, meaning a cargo can be transported by multiple 
importins or exportins. Elucidating the specific transport factors that are responsible for 
the shuttling of TR is of fundamental importance because of the receptor’s direct influence 
on thyroid hormone regulatory functions. Another important factor is the “signals” that 
determine the interaction between TR and importins and exportins. In this case, prior 
studies have shown that TRα1 has two nuclear localization signals (NLSs) and least three 
nuclear export signals (NESs) for importin and exportin recognition, respectively 
(Mavinakere et al., 2012). In contrast, TRβ1 only has one NLS Therefore, it is of interest 
to determine which NLS or NES of TR interacts specifically with which importin(s) or 
exportin(s).  
The main goal of this thesis research was to determine which importins directly 
mediate the nuclear import process of TR. Additional work addressed which exportins 
directly mediate TRα1’s nuclear export. RNA interference (RNAi)-based knockdown of 
specific importins, analysis of TR distribution by fluorescence microscopy, and “GFP-trap” 
coimmunoprecipitation assays were the main approaches used in the thesis. A detailed 
review of the literature on THs, TRs, transport factors, and the main experimental 
approaches are provided in the following sections and in Chapter 2. 
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Thyroid Hormone & Thyroid Hormone Receptors 
Thyroid Hormone (TH) 
Thyroid hormones (THs) have major influences on development, growth, 
metabolic efficiency, thermogenesis and energy expenditure, and are involved in cross-
talk with other hormones (Hikunguwo et al., 2007). TH disorders not only cause irregular 
development of brain tissues, muscles, bone structures and neuronal activity (Yeshuda-
Shnaidman et al., 2013), but also are involved in the development of certain diseases like 
breast cancer (Onde et al., 2006). Without a doubt, THs influence every cell in our body.  
Production of TH follows a tightly regulated positive feedback pathway from the 
hypothalamus to the pituitary to the thyroid gland (Furumoto et al., 2005) (Figure 1). The 
signal starts with the secretion of thyrotropin-releasing hormone (TRH) by the 
hypothalamus into the blood (Klieverik et al., 2009). TRH eventually travels to the pituitary 
gland and upregulates the secretion of thyroid stimulating hormone (TSH) (Wolf, 2002).  
TSH binds with the thyroid stimulating hormone receptor (a G protein-coupled receptor) 
on the thyroid gland epithelial cells, which contributes to the secretion of thyroglobulin—
the precursor of THs (Linke et al., 2002). Thyroglobulin gets iodinated by a protein called 
thyroperoxidase (Haddow et al., 2010). The iodinated thyroglobulin includes two types of 
molecules, thyroglobulin with one iodine bound is called monoiodotyrosine (MIT), while 
thyroglobulin with two iodines is called diiodotyrosine (DIT) (Mansourian, 2011). The 
combination of one MIT and one DIT yields one molecule of triiodothyronine (T3), and a 
combination of two DIT produces one molecule of thyroxine (T4) (Dunn, 2001). 
Interestingly, T4 is entirely synthesized within the thyroid gland, while only a few percent 
of the total hormone produced by the thyroid gland is T3 (Senese et al., 2014).  Based on 
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the fact that T3’s activity is 10 times higher than T4’s activity (Wawrzynska et al., 2003), 
and a large amount of T4 will be de-iodinated to T3 in tissues other than the thyroid 
(Braverman et al., 1970), T4 is viewed as the “pro-hormone” of T3. T4 also has a longer 
half-life time, meaning it is more stable than T3. In the circulatory system, 99.97% of total 
T4 and 99.7% of total T3 are bound with three different thyroid hormone carrying 
proteins—thyroxine-binding globulin (TBG), transthyretin (TTR), and human serum 
albumin (HAS) (Pappa et al., 2015). As the name indicates, TBG has the highest binding 
affinity to T4 in serum. Cell membrane transporters are essential for THs to enter the 
cytoplasm because of the cell membrane’s relative impermeability towards THs (Cheng, 
et al., 2010). In addition, literature published by Yen (2001) and Bassett (2003) suggested 
the existence of a cell membrane receptor for TH (Davis et al., 2005). Recently, integrin 
αVβ3 was identified as a cell membrane receptor for TH (Bergh et al., 2005). Integrin 
αVβ3 is also known for regulating signal transduction pathways such as MAPK (D'Arezzo, 
et al., 2004), which means TH not only has genomic regulatory functions (performed 
through binding its nuclear receptor, TR) but also possesses non-genomic regulatory 
functions of activating cell signaling pathways.  
As mentioned earlier, most T4 will be de-iodinated to T3 after it enters a target cell. 
This TH deiodination process is regulated by several deiodinase isoforms: deiodinase 1 
(D1), deiodinase 2 (D2), and deiodinase 3 (D3) (Bianco et al., 2002). D1 and D2 are the 
enzymes that convert T4 to T3. The main difference between them is that they are 
expressed in different tissues. For example, D1 is expressed more in liver and kidney 
tissues and D2 activity is present in different muscles, brain, and brown adipose tissues 
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Figure 1. Thyroid hormone regulation pathway. The hypothalamus 
releases thyrotropin-releasing hormone (TRH) which has a positive influence on the 
anterior pituitary gland. The stimulation causes the synthesis of thyroid stimulating 
hormone (TSH). TSH acts on the thyroid gland which produces the thyroid hormones, T4 
and T3. The amount of free thyroid hormone and T3’s inactive form, reverse T3, give 
negative feedback to the anterior pituitary to downregulate this pathway (adapted from 
Razani, 2010). 
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(Pilo et al., 1990). D3, on the other hand, converts T3 to an inactive form termed reverse 
T3 (r-T3), which in turn maintains T3 homeostasis by downregulating its production 
(Bianco, 2011). It is interesting to note that both TH genomic and non-genomic functions 
are turned on and off by maintaining the T3/r-T3 balance via D3 deiodination (Gereben 
et al., 2008). It is safe to assert, however, that the TH pathway involves an extremely 
complicated and organized system, at the crux of which lies the thyroid hormone receptor. 
 
Nuclear Receptors 
Outside of the nuclear receptor field, there is a common misconception that nuclear 
receptors and cell membrane receptors are similar. As a matter of fact, cell membrane 
receptors and nuclear receptors belong to a common receptor category but are totally 
different in their mechanism of action. The term “receptor” describes a protein that triggers 
a response when binding of a signal molecule causes the receptor to undergo a 
conformational change (Purves et al., 2001). For signal molecules that are impermeable 
to the membrane, cell membrane receptors will interact with them on the extracellular 
surface and activate a downstream signaling transduction cascade. When signal 
molecules are permeable to the cell membrane, or have specific transporter proteins, they 
cross the membrane and bind with intracellular receptors, called nuclear receptors, that 
are able to shuttle between the nucleus and cytoplasm. The nucleocytoplasmic shuttling 
property of nuclear receptors allows direct ligand-dependent gene regulation (Purves et 
al., 2001). Nuclear receptors are a superfamily of ligand-regulated transcription factors 
that are activated by steroid hormones (e.g., androgen, estrogen, progesterone), or other 
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ligands such as vitamin D and thyroid hormone (Sever and Glass, 2013). Four subtypes 
of nuclear receptors have been discovered so far. Receptors like androgen receptors and 
estrogen receptors are type 1 receptors. They are usually protected and anchored by 
chaperones in the cytoplasm (Echeverria and Picard, 2010). When the correct ligand 
binds with a type 1 receptor, the conformational change will cause the release of 
chaperones and then the exposure of a nuclear localization signal (NLS). The exposed 
NLS recruits importins to transport the ligand-receptor complex into the nucleus to 
activate gene transcription (Glass and Rosenfeld, 2000). In contrast, type 2 receptors, 
such as thyroid hormone receptors (TRs), are primarily located in the nucleus. When 
there is no ligand, they form either homodimers, or heterodimers with retinoid X receptor 
(RXR), on their DNA response elements to repress target gene transcription. 
Corepressors like NCoR and SMRT are recruited and help with the repressive function 
(Chen and Evans, 1995). The homodimers or heterodimers of type 2 receptors are 
dissociated from the corepressors in the presence of ligand, and coactivators are 
recruited by the ligand-receptor complex to promote gene transcription. Type 3 receptors 
have a similar function as type 1; type 4 receptors bind to half-site hormone response 
elements as monomers (Mangelsdorf et al., 1995). This thesis focuses on one group of 
type 2 receptors, the thyroid hormone receptors.  
Thyroid Hormone Receptors 
  As mentioned in the nuclear receptor section, in most cases, unliganded TRs 
repress target gene transcription while liganded TRs do the opposite (Chassande et al., 
2003).  The reason TRs are referred to as a group is because they are encoded by two 
separate genes: the α c-erbA gene on chromosome 17 encodes TRα; the β c-erbA gene 
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on chromosome 3 encodes TRβ (Lazar, 1993; Brent, 1994). Moreover, TRα and TRβ 
each has multiple isoforms (Figure 2). TRα’s three isoforms (TRα1, TRα2, and TRα3) are 
generated by alternative splicing of the primary transcript of the α c-erbA gene (Hahm et 
al., 2014). Only TRα1 shows high affinity for T3, whereas TRα2 and TRα3 do not interact 
with any form of TH (Moran et al., 2014). TRβ isoforms (TRβ1, TRβ2, and TRβ3) are the 
result of alternative promoter usage within the β c-erbA gene (Williams, 2000; Tagami et 
al., 1998). These three isoforms’ sequences are highly conserved, especially their DNA 
binding domain and ligand binding domain (Navarrete-Ramírez et al., 2014). Although 
TRα1 and TRβ1 are both ubiquitously present, the ratio of their expression in different 
tissues tends to vary (Sadow et al., 2003). For example, TRα1 is expressed dominantly 
in different muscle, bone and adipose tissues while TRβ1 is more expressed in liver, 
kidney, and brain tissues (Pascual and Aranda, 2013). A more detailed list of TRs’ roles 
in different cell types is provided in Table 1. Although this thesis research primarily 
focused on TRα1, experiments on TRβ1 are also presented.  
 
Thyroid Hormone Response Elements 
Since the critical importance of TH has been emphasized multiple times, it is not 
surprising that at least 100 genes in humans are TH responsive (Feng et al., 2000).  TH-
responsive genes have TH response elements (TREs) that function as enhancers or 
silencers. TREs are the DNA sequences to which TRs bind, and are usually located within 
the non-coding regions on the target DNA (Yen et al., 2006). There are a number of 
different TRE sequence motifs, which might explain how TR differentily modulates 
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transcription in various tissues (Hartong et al., 1994). Whether TR activates or represses 
gene transcription depends on the property of the TRE (Wu and Koenig, 2000). At a 
positive TRE, unliganded TR represses transcription but switches to activating 
transcription when T3 binds to it. At a negative TRE, unliganded TR promotes 
transcription whereas T3-bound TR is repressive. 
 
TRα1 Structure and Regulatory Activity 
Much research has been conducted on the impact of different TR variants using 
TR knockout mice (Ribeiro et al., 2001). For example, TRα1 mostly regulates 
thermogenesis, while TRβ1 turns out to be essential for cholesterol metabolism (Wikstrom 
et al., 1998). However, the functional and expression level differences in various tissues 
do not mean that TR isoforms work in isolation. According to Tinnikov and coworkers’ 
2002 paper, both expression and activity of TRα1 arise after TRβ1 suppression, meaning 
there is interplay between the two dominant variants. TRα, TRβ and their isoforms share 
a common protein structure (Figure 2a). This common structure includes multiple 
functional regions: a less-conserved N-terminal A/B region, a highly conserved DNA 
binding domain, a short hinge region and a C-terminal ligand binding domain. The N-
terminal A/B domain (NTD) contains a constitutive autonomous activation function 1 
domian (AF-1), which is used to regulate transcription. Compared to the other domains, 
the NTD is the most divergent and less well-characterized (Thuestad et al., 2000). The 
NTD, however, contributes to transcriptional activation significantly through AF-1. 
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Figure 2. TR isoforms and their general structure. The general structure of 
thyroid hormone receptor’s four functional domains is represented in a). Different TRα 
and TRβ isoforms are listed in b) (adapted from Bassett, 2003). Numbers indicate amino 
acid residues. 
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Table 1. The role of TR in the development of selected cell types  
 
(Adapted from Pascual, 2013) 
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Furthermore, it has been documented that the NTD also regulates transcription activation 
through interacting with the ligand binding domain (Huber et al., 2003; Tian et al., 2006). 
An extremely exciting property of the NTD that needs to be mentioned for the sake of this 
thesis is that a novel nuclear localization signal, NLS-2, is found in this domain in TRα1, 
meaning that the NTD is also involved in nuclear import (Mavinakere et al., 2012). 
The DNA binding domain (DBD) of most nuclear receptors is highly conserved with 
regard to both structure and sequence (Chen and Young, 2010) (Figure 3). At least 40% 
of the sequence (66 amino acids) is identical among all nuclear receptors (Gronemeyer, 
1995). There are two zinc-binding motifs and two α-helices in the main region sequence 
(two zinc fingers). Each zinc-binding motif contains four conserved cysteine residues (Lee 
et al., 1993). The first zinc finger contains a P box that regulates TRα1-DNA interaction 
by binding with phosphate groups of a TRE’s major groove (Oetting and Yen, 2007), 
whereas the D box of the second zinc finger binds to a TRE’s minor groove. A charged 
C-terminal extension region (CTE), following the second zinc finger, regulates the DBD’s 
interactions with other proteins as well as DNA (Zilliacus et al., 1995). The CTE has a 
short T box region at the very beginning. This T box region facilitates the dimerization of 
the TRα1-RXR heterodimer, which represses gene transcription when T3 is absent 
(Rastinejad et al., 1995).  
TRα1’s hinge domain (D domain) is a short bridge between the DBD and ligand 
binding domain (LBD) (Nascimento et al., 2006). Originally, the hinge domain was 
considered to be no more than a flexible rotation “joint” between the DBD and LBD that 
helps different nuclear receptors to mediate their conformations to adapt to different  
13 
 
          
 
Figure 3. TR DBD CTE structure. A schematic diagram of the full-length 
TR and its DBD domain. The core sequence has two zinc-binding motifs and two α-
helices. The C-terminal extension region (CTE) contains a T-box region (adapted from 
Chin, 2010). 
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response elements (Baniahmad et al., 1992). 
However, more and more functional elements of the hinge domain have been 
proposed ever since. For example, Baniahmad et al.’s 1995 paper reported an activation 
element on TR’s hinge domain, and a couple of sequences that appeared to be essential 
for efficient DNA binding. TR’s hinge domain has also been suggested to be essential for 
TH-binding (Lin et al., 1991), and to have corepressor binding sites (Horlein et al., 1995). 
More importantly, the hinge domain contains a nuclear localization signal, NLS-1, that 
directs the nuclear import process (Mavinakere et al., 2012).  
Recall that the AF-1 domain is located in the NTD. In addition, another ligand-
dependent autonomous activation function domain, AF-2, is found in the C-terminal ligand 
binding domain (LBD) (Aranda et al., 2001). AF-2’s crucial property of regulating 
transcriptional activation was confirmed by X-ray crystallography (Wurtz et al., 1996). 
TR’s LBD is the most complex domain to study because of its various activities, including 
ligand binding, nuclear export, receptor dimerization and hormone-induced transcriptional 
activation or repression (Wu and Koenig, 2000). The LBD was suggested to have an 
essential role in mediating TR-RXR heterodimer or TR homodimer formation because of 
the conserved ninth heptad close to the C-terminus. The crystal structure of TRα1 
revealed that the LBD contains twelve α-helices and a couple of β-turns, which is believed 
to fold into a hydrophobic binding pocket for ligand (Wagner et al., 1995).  Among the 
twelve helices, helices 3 and 5 of unliganded TRα1 recruit corepressor proteins to 
suppress transcription (Bassett et al., 2003). The two major LBD recruited corepressors 
are nuclear receptor corepressor (NCoR) and silencing mediator of RAR and TR (SMRT). 
Besides their own inhibitory effects, NCoR and SMRT also recruit histone deacetylases, 
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which repress transcription by promoting chromatin condensation (Hu and Lazar, 1999). 
The TR-DNA-corepressor complex causes a non-permissive chromatin structure and 
inevitably inhibits the basal transcriptional machinery (Rosenfeld and Glass, 2001).  
When T3 binds with the hydrophobic pocket, the LBD changes its conformation to 
rearrange the position of helix 12. This conformational change of helix 12, the AF-2 
domain specifically, triggers the release of corepressors and generates a surface for 
coactivators to bind. One of the three nuclear export signals (NESs), NES-H12, overlaps 
with the AF-2 domain. SRC1 and p160, for example, are coactivators possessing histone 
acetyltransferase (HAT) activity that “opens” up chromatin for transcription. More 
coactivators that have HAT and histone demethylase activities will be recruited. Some 
crucial coactivators, such as TR associated proteins (TRAPs), might not possess HAT 
activity but are capable of regulating the binding of RNA polymerase II to a target gene’s 
promoter (Fondell et al., 1999). The existence of two distinct groups of coactivators 
(coactivators with HAT activity and coactivators without HAT activity) suggests that there 
are two steps for liganded TRα1 to promote transcription. First, the recruitment of 
coactivators with HAT activity (SRC1/p160) triggers chromatin modification. Second, after 
“opening up” DNA by chromatin remodeling, coactivators without HAT activity (TRAPs) 
are recruited to promote transcription by interacting with the basal transcription complex 
and RNA polymerase II. Although these two steps seem to be exclusive, the two groups 
of coactivators actually help each other like co-workers. For instance, other than 
remodeling chromosome structure by acetylating histones, HAT coactivators can also 
acetylate non-histone proteins such as the basal transcription factors TFIIE and TFIIF. 
This post-translational modification of TFIIE and TFIIF is crucial for the formation of the 
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basal transcription complex (Lee et al., 2003). Last, but not least, one of the LBD’s 
activities that is related to this thesis is mediating TRα1 nuclear export. Multiple nuclear 
export signals have been discovered in the LBD of TRα1 (Mavinakere et al., 2012). 
Nucleocytoplasmic Transport 
   A eukaryotic cell has a nuclear envelope that serves as a defensive wall around 
the nucleus to maintain an intracellular compartmentalization. Important content such as 
DNA and nuclear proteins are strictly kept in the nucleus, while large cytoplasmic 
components are not allowed to freely enter. Proteins with a molecular mass of less than 
40 kilodalton (kDa), however, can passively diffuse through the nuclear envelope, either 
from nucleus to cytoplasm or cytoplasm to nucleus (Cooper, 2000). Larger proteins that 
have important regulatory or structural functions in the nucleus need to be assisted to 
cross the nuclear envelope and, in some cases, to then return to the cytoplasm. This 
process is called nucleocytoplasmic transport. The following section provides a detailed 
review of each element involved in the nucleocytoplasmic transport pathway, including 
the nuclear envelope, nuclear pore complex, importins and exportins, and the energy 
source that drives the entire cycle. 
The “Wall” – The Nuclear Envelope 
 The nuclear envelope is a bilayer membrane made of phospholipids. The layer 
facing the cytoplasm is called the outer nuclear membrane (ONM), and the layer facing 
the nucleus is called the inner nuclear membrane (INM) (D'Angelo et al., 2006). The 
space between the membranes is called the perinuclear space, which is continuous with 
the rough endoplasmic reticulum (ER) through the ONM (Gerace and Burke, 1988). The 
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ONM provides binding sites for structural proteins in the cytoplasm, whereas the INM 
associates with the lamina and chromatin in the nucleus through membrane-associated 
proteins (Burke and Stewart, 2002). When you look at a eukaryotic cell, the nucleus is 
always positioned at a non-centered location. This specific location of the nucleus is 
essential for various cell activities, and is mediated by a conserved group of nuclear 
membrane proteins that are believed to be the ONM proteins (Padmakumar et al., 2004).  
According to Murray and Davies’s classic work in 1979, heterochromatin in the 
nucleus is tightly bound to the INM in mammalian cells. Much later evidence also 
established the existence of INM-associated regions of chromatin (Marshall, 2002). 
Studies have suggested that the INM is involved in the coordination of chromatin 
organization (Hochstrasser et al., 1986), which explains how chromosomes are separated 
from each other into their relatively “exclusive” territories (Razin et al., 2004). The lamina 
is a layer of intermediate filaments underneath the INM that maintains nuclear integrity 
(Holaska et al., 2003).  The main component of the lamina is the lamin proteins, one of 
the three classes of proteins that interact with chromatin. The lamina layer functions as a 
“molecular shock absorber” (Dahl et al., 2004) that relieves the tension on the nuclear 
envelope (Hutchison et al., 2001) and, in turn, helps to maintain nuclear integrity.  
 
The “Gate” – The Nuclear Pore Complex  
The nuclear envelope’s two layers, the INM and ONM, are functionally different 
from each other but are linked by nuclear pore complexes (NPCs) as a whole. The NPC 
functions as the communicator between the cytoplasm and the nucleus (Sorokin et al., 
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2007). The complex is about 60,000 kDa in vertebrates, and is an assembly of at least 30 
different types of proteins called nucleoporins (D’angelo and Hetzer, 2006). Each type of 
nucleoporin has multiple copies, which brings the total protein number to 500-1000 per 
NPC (Cronshaw et al., 2002). The 30 types of nucleoporins can be divided into two 
classes: class one nucleoporins (usually form the NPC’s cytoplasmic filaments) have FG 
repeats that are used to interact with transport factors; class two nucleoporins that lack 
FG repeats are the structural components of the NPC (Weis, 2002; Rout and Aitchison, 
2001). Although the NPC is assembled from multiple copies of 30 types of nucleoporins 
encoded by a relatively small number of genes, each of them occupies multiple, distinct 
biochemical environments (Lin et al., 2016). The majority of the nucleoporins are 
distributed symmetrically, explaining the basket shape structure (Rout et al., 2001).  
Nuclear receptors, soluble proteins, and RNAs are transported through the central 
channel of the NPC (Suntharalingam and Wente, 2003). When smaller proteins or ions 
passively diffuse through the NPC, they do not physically bind to the nucleoporins, and 
the diameter of the channel is only about 10 nm (Bustamante, 1993). Large proteins like 
TRα1 need to be brought to the NPC by transport factors. Cargo-bound transport factors 
interact with nucleoporins, which triggers the NPC channel to enlarge the diameter to 40 
nm (Panté and Kann, 2002). This conformational change makes the transport process of 
large proteins much faster. Although it is possible for ions and smaller proteins to diffuse 
through the channel, most proteins are selectively blocked by the NPC. The selectivity 
could be explained by the presence of a group of hydrophobic nucleoporins lining the 
center of the NPC channel (Siebrasse and Peters, 2002). A very interesting fact about 
the NPC is that among all the nucleoporins there is no ATPase or GTPase. It means that 
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even though the NPC mediates the nucleocytoplasmic transport of large proteins, the 
energy for selective transport is neither provided by the transport factors nor by the NPC. 
The “Shuttle”—Transport Factors 
 As mentioned previously, small molecules and ions can passively diffuse though 
the NPC, but proteins bigger than 40 kDa need to be recognized and brought in to the 
nucleus by a group of cytosolic proteins called transport factors. Most of the 
macromolecules are transported by a group of evolutionarily conserved karyopherin-β 
family transport factors. Karyopherins that are in charge of importing cargo into the 
nucleus are called importins, whereas those that are in charge of exporting cargo back to 
the cytoplasm are exportins. Karyopherins have two major binding targets: they interact 
with macromolecular cargo, and they interact with nucleoporins (Soniat and Chook, 
2015). Nuclear proteins that can be recognized by karyopherins contain nuclear 
localization signals (NLSs) and may also contain nuclear export signals (NESs). Those 
signals are within the protein’s amino acid sequence. NLSs direct nuclear import by 
binding with importins while NESs direct nuclear export by interacting with exportins (Xu 
et al., 2010). Besides interacting with protein cargo, karyopherins also weakly bind to FG 
repeats in nucleoporins to bring the cargo to the NPC (Fung and Chook, 2014).  
 At least 20 β-family karyopherins have been identified in humans. They have 
similar molecular masses and all contain multiple HEAT repeats, but their sequences are 
90% different from each other (O'Reilly et al., 2011). Each of them is able to transport a 
distinct group of cargo, but most proteins appear to utilize multiple karyopherins for 
transportation (Chook and Süel, 2011). This explains how such a small group of proteins 
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does the work of transporting millions of macromolecules. Among the 20 karyopherins, 
11 are either importins that only import cargo into the nucleus or bidirectional transporters 
that also possess exportin function (Chook and Blobel, 2001). These karyopherins belong 
to the karyopherin-β family (Soniat and Chook, 2015), and mostly interact with their cargo 
directly. But some of them, importin β1 for example, require an adaptor protein called 
karyopherin-α (also known as importin α) to assist the cargo-recognizing process by 
binding with a classic NLS within the cargo polypeptide chain. Importin α acts as the 
mediator between karyopherin-β family importins and nuclear proteins, and is the most 
studied adapter importin (Conti et al., 1998). In the following content, all the importins will 
be referred to as “IPO + number.” An interesting note is that although karyopherins shuttle 
proteins between the cytoplasmic and nuclear compartments, they do not necessarily 
determine the direction of transport. Which compartment the protein cargo stays in 
depends on the gradients of Ran GTP and Ran GDP. 
Karyopherin/Importinα (IPOα) 
As an adaptor protein, IPOα interacts with IPOβ1 and recognizes protein cargo 
with a classical NLS to form the complete classical import complex. In other words, cargo 
that contains a classical NLS is imported by a IPOα-IPOβ1 heterodimer (Pemberton et 
al., 1998). Ever since the classical pathway was identified, many other different import 
pathways have been discovered. Compared to the classical NLS, which is made of one 
or two segments of basic residues (Pemberton et al., 1998), nonclassical NLSs directing 
other import pathways usually contain more diverse sequences and bind with other 
unidirectional karyopherin-β family importins directly. Although this indicates that IPOα 
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only works as a mediator for the indirect binding between cargo and IPOβ1, most proteins 
possess classical NLSs. Studies even suggest that IPOα and IPOβ1 have crucial 
regulatory functions in mitosis because they act as chaperones to protect the major 
factors involved (Gruss et al., 2001; Nachury et al., 2001; Wiese et al., 2001).  
IPOα is composed of three structural units: a positively charged N-terminal domain 
that binds IPOβ1 (IBB domain), a central NLS-binding domain with 10 ARM repeats that 
recognizes a variety of classical NLSs, and a hydrophilic C-terminal domain (Chook and 
Blobel, 2001). IPOα’s affinity for substrates is regulated by binding to IPOβ1 (Fanara et 
al., 2000). According to Moroianu et al. (1996), when IPOα is not binding with IPOβ1, a 
classical NLS-like sequence in the positively charged N-terminal domain binds to the 
ARM repeats of the NLS-binding domain which auto-inhibits the interaction with 
substrates. IPOβ1 binding to IPOα’s N-terminal releases the ARM repeats, which explains 
why the IPOα-IPOβ1 heterodimer has a higher affinity for NLSs. When IPOα is released 
from IPOβ1 and cargo in the nucleus, a karyopherin-β family exportin called CAS (cellular 
apoptosis susceptibility) binds to the tenth ARM repeat and exports the free IPOα under 
a high Ran GTP concentration (Kutay et al., 1997). This export pathway is part of the 
IPOα-cargo dissociation mechanism since CAS binding and NLS binding are mutually 
exclusive (Herold et al., 1998).  
Karyopherin-β family members are encoded by separate genes in all eukaryotes, 
whereas IPOα has at least seven family members (Pumroy and Cingolani, 2015). Human 
IPOα family members have more than 40% conservation and 26% identity in their 
sequences (Henikoff and Henikoff, 1992). The IPOα family is divided into three 
subfamilies, based on karyopherin nomenclature (Figure 4): α1 subfamily including IPOα1 
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and IPOα8; α2 subfamily including IPOα3 and IPOα4; and α3 subfamily including IPOα5, 
IPOα6, and IPOα7 (Pumroy and Cingolani, 2015). IPOα1 and IPOα8 of the α1 subfamily 
share 55% identity (Weis, et al., 1995). IPOα1, also known as SRP1 or Rch1, is 
considered to be the general adaptor importin for classical NLS containing cargo. Its 
mouse homologue, IPOα2, sharing 99.2% similarity to IPOα1, has been used in a variety 
of studies (Kobe, 1999). Since the other α1 subfamily member, IPOα8, was just recently 
discovered, only a little is known about it, besides being overexpressed in prostate cancer 
(Kelley et al., 2010; Laurila et al., 2014).  
A year after the discovery of IPOα1, the α2 subfamily’s two members, IPOα3 and 
IPOα4, were identified and put in the same group for their 86% identity (Takeda et al., 
1997). However, even though these two proteins are almost identical, only IPOα3’s crystal 
structure has been revealed very recently (Pumroy et al., 2015). Both IPOα3 and IPOα4 
are known for their capacity of transporting important substrates like RCC1 (regulator of 
chromosome condensation 1) (Köhler et al., 1999), RanBP3, and transcription factor NF-
κB (p50/p65) (Fagerlund et al., 2005). The last subfamily, including IPOα5, IPOα6, and 
IPOα7, is believed to be the earliest branched off group in evolution due to its yeast 
homologs (Mason et al., 2009). The three subfamily members share 74% identity, which 
makes it difficult to distinguish their functions. The only difference within the subfamily is 
that IPOα6 is strictly expressed in the testis (Köhler et al., 1997). Although determining 
their distinct cargo has not been realistic, important regulatory factors, such as 
phosphorylated STAT1 (signal transducer and activator of transcription 1), have been 
reported to use IPOα3 subfamily isoforms (Sekimoto et al., 1997). 
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Figure 4. Evolution of importin α. The IPOα family is divided into three 
subfamilies: α1 subfamily including IPOα1 and IPOα8; α2 subfamily including IPOα3 and 
IPOα4; and α3 subfamily including IPOα5, IPOα6 and IPOα7. From left to right is a 
schematic diagram of the evolution of the importinα family in Saccharomyces cerevisiae, 
Drosophila sp. and Homo sapiens (adapted from Pumroy, 2015). 
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Table 2. Alternative names of importin α isoforms.  
 
Table 3. Selected cellular cargoes specific to importin α isoforms. 
 
(Adapted from Pumroy, 2015) 
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Karyopherin-β family 
Twenty β family karyopherins have been identified in humans. All β karyopherins’ 
molecular masses are between 90 to 150 kDa. They share low sequence identity but the 
helical HEAT repeats are conserved (Chook and Süel, 2011). As mentioned earlier, 11 
out of the 20 human β family karyopherins can import proteins into the nucleus. They are 
either unidirectional importins (IPOβ1, IPOβ2, IPO4, IPO5, IPO7, IPO8, IPO9, IPO11, 
IPO13) that each serves a specific set of cargos, or bidirectional transporters (Trn-SR and 
exportin 4) possessing export function. Besides IPOβ1 which requires the adaptor protein 
IPOα to import cargos, the rest of the unidirectional IPOs bind to their cargo’s nonclassical 
NLS directly without forming heterodimers with IPOα, due to their Ran-binding domains 
(Kortvely et al., 2005). 
IPOβ2 is the only importin that requires simultaneous binding with both 
nucleoporins and cargo (Bonifaci et al., 1997). Numerous mRNA binding proteins and 
nuclear proteins are imported by IPOβ2 specifically (Lee et al., 2006), which indicates 
that IPOβ2 recognizes a diverse set of non-classical NLSs. The term PY-NLS was given 
to all the NLSs that bind IPOβ2, based on the fact that they share common biochemical 
and structural characteristics while being completely different from each other (Lee et al., 
2006). Since a PY-NLS contains either a N-terminal hydrophobic motif or a N-terminal 
basic motif, PY-NLSs are divided into hydrophobic or basic subclasses. This explains how 
IPOβ2 is able to recognize the basic and hydrophobic cargos that are chemically diverse 
(Cansizoglu et al., 2007). 
26 
 
Compared to the divergent cargo imported by IPOβ2, IPO4’s target set is relatively 
unexplored. Only four protein cargos have been identified so far: ribosomal protein 
(rPS3a), vitamin D receptor (VDR), hypoxia-inducible factor (HIF1-α), and transition 
protein 2. The common property is that they are all basic proteins (Chachami et al., 2009; 
Jäkel et al., 2002). Since the mechanism of binding between IPO4 and cargo is unclear, 
it is highly possible that these four proteins use other importins for transport as well. For 
example, Chachami and coworkers’ 2009 paper indicates that IPO7 is also involved in 
the import of HIF1-α. The yeast homolog of IPO4, Kap123p, is the second choice for 
many cargos that are originally imported by yeast Kap121p (Quan et al., 2008), whereas 
some proteins that are Kap123p-specific use Kap121p as a backup plan. Yeast Kap121p 
is the homolog of human IPO5’s homolog in human (Leslie et al., 2004). Therefore, it is 
possible that IPO4 and IPO5 have similar characteristics, and might have overlap with 
each other’s cargo sets. Like its yeast homolog, IPO5 also imports core histone proteins 
(Mühlhäusser et al., 2001). Twenty different types of cargo have been reported but only 
a few of them are IPO5 specific, such as transcription regulator PGC7/Stella (Heese et 
al., 2004; Nakamura et al., 2007). 
IPO7 caught scientists’ attention not only because of its tremendous cargo pool 
but also for the fact that it is so far the only known β-family karyopherin that can import 
cargos by interacting with another karyopherin, IPOβ1. The IPO7-IPOβ1 heterodimer has 
been reported to import cargos such as linker histone H1 (Jäkel et al., 2002), human 
immunodeficiency virus 1 (HIV-1) integrase (Zaitseva et al., 2002), and Adenovirus core 
protein pVII (Wodrich et al., 2006).  
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There is a large number of proteins that are primarily transported by IPO7, such 
as the zinc finger protein (EZI) (Saijou et al., 2007), ERK-2 kinase, Smad3 (Chuderland 
et al., 2008), histone core proteins (Mühlhäusser et al., 2001), HIV-1 reverse transcription 
complex (RTC) (Zaitseva et al., 2002), and proline-rich homeodomain (PRH) (Ploski et 
al., 2004). IPO7 not only recognizes various conformational epitopes such as certain zinc 
fingers, PAS domains (Chachami et al., 2009) and leucine-zipper domains (Waldmann et 
al., 2007), but also interacts with diverse linear recognition epitopes. Moreover, the fact 
that IPO7 imports the HIV-1 RTC supports the idea that eukaryotic cells use IPO7-
dependent transport pathway to uptake endogenous and exogenous DNA (Dhanoya et 
al., 2013). 
IPO8 is quite similar to IPO7. They share 68% identity, which makes them the most 
identical relative to other karyopherin pairs (Chook and Süel, 2011). IPO8 has not yet 
been extensively explored. No NLS specific for IPO8 recognition has been determined 
yet. Although proteins such as Smad3, Smad4, Argonaut protein 2 (Ago2) (Weinmann et 
al., 2009), and Signal recognition particle protein 19 (SRP19) (Dean et al., 2001) can to 
be imported by IPO8, most of them are primarily imported by other importins. 
IPO9 is also responsible for importing a large number of cargos. Examples are 
hepatocellular carcinoma-associated protein (Jäkel et al., 2002), Aristaless (Arx) (Lin et 
al., 2009), c-Jun (Waldmann et al., 2007), PP2A (Lubert and Sarge, 2003), and the 
histone core proteins H2A, H2B, H3, and H4 (Baake et al., 2001). Although the NLSs of 
IPO9’s cargos appear to be quite different from each other, the common characteristic  
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Table 4. Nuclear import cargos of IPO4, IPO5, IPO7, IPO 7/β1, IPO8, 
IPO9, IPO11, and IPO13  
 
 
 
 
29 
 
 
 
(Adapted from Pumroy, 2015) 
 
30 
 
shared by all the NLSs is their positively charged sequences. IPO9’s yeast homolog 
Kap114 also has a large cargo pool. In addition to transporting important proteins like 
histone chaperone Nap1p (Mosammaparast et al., 2005), in yeast, Kap114 also appears 
to mediate the assembly of the transcription initiation complex due to its interaction with 
both TFIIB and the TBP domain (Kim et al., 1993; Liu et al., 2010). IPO9’s ability to interact 
with such a large group of cargo is impressive, but what truly makes it outstanding is its 
cytoplasmic chaperone function (Kortvely et al., 2005). Compared to the IPOα-IPOβ1 
heterodimer’s weak chaperone function, IPO9 effectively shields basic cargo proteins 
from degradation and aggregation (Jäkel et al., 2002). 
IPO11’s cargo pool includes ubiquitin-charged class III E2 Ub conjugating 
enzymes UbcM2, UbcH6, UBE2E2 (Plafker et al., 2004), ribosomal protein L12 (rpL12) 
(Plafker and Macara, 2002) and Gag polyprotein of Rous Sarcoma Virus (Gudleski et al., 
2010). The three E2 Ub conjugating enzymes are primarily imported by IPO11, but the 
fact that only multiprotein complexes of the E2 enzymes can be recognized by IPO11 
makes it nearly impossible to identify the NLSs. Meanwhile, the NLS of rpL12 has not 
been explored, although IPO11 appears to be rpL12’s only transporter. The very first 
identified NLS of IPO11 cargo is the 5-helix MA domain located in the N-terminal of Gag 
(RSV) (McDonnell et al., 1998).  
Among all the β family importins that were investigated in this thesis, IPO13 is the 
only bidirectional karyopherin that mediates both import and export of certain cargos 
(Grünwald et al., 2013). Proteins that are imported by IPO13 are paired-type 
homeodomain transcription factors PAX 3 and PAX 6 (Ploski et al., 2004), core exon 
junction complex components Mago-Y14 (Bono et al., 2010), Aristaless (Arx) (Lin et al., 
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2010), glucocorticoid receptor (GR) (Tao et al., 2006) and five other proteins. The 
characterized IPO13 recognition sites are predominantly folded domains; for example, 
both Arx and PAX 6 bind IPO13 through small helical homeodomains (Ploski et al., 2004). 
The large non-overlapping surfaces explain, in part, how IPO13 recognizes so many 
different cargos, and subsequently leads to a different releasing mechanism for the 
cargos. Initially, IPO13 was defined as an importin. However, the first export cargo of 
IPO13, eukaryotic initiation factor 1A (eIF1A), was discovered by Mingot et al. in 2001. 
eIF1A, along with other translation factors, is directly involved in the forming of the 
translational pre-initiation complex through interacting with the small ribosomal subunit 
(Jackson et al., 2010). But due to its small size (18 kDa), an active export pathway is 
required to maintain the cytoplasmic localization of eIF1A. The structure of the RanGTP-
IPO13-eIF1A complex illustrates that eIF1A binds to the inner surface of IPO13’s C-
terminal arch.  The binding of RanGTP to IPO13 stabilizes eIF1A rather than competing 
with the cargo, since their binding sites do not overlap (Grünwald et al., 2013). This cargo 
stabilizing function, which does the opposite of the unidirectional importins, allows IPO13 
to perform double duty (Mingot et al., 2001). The IPO13 transport cycle allows two cargos 
to be transported in opposite directions by consuming only one GTP molecule. After 
eIF1A is exported out of the nucleus, import substrates bind IPO13, which triggers the 
cytoplasmic release of eIF1A. 
Ran-dependent Directional Transport 
 Although karyopherins are the “shuttles” that import and export cargo, they do not 
control the transport direction. Whether a karyopherin transports cargo from the 
cytoplasm to the nucleus (importins) or does the opposite (exportins) is driven by the Ras-
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related small GTPase (Ran) system (Moore and Blobel, 1993). Ran has two forms: GTP-
bound and GDP-bound. RanGTP hydrolysis is activated by the cytoplasmic GTPase 
activating protein (RanGAP) to RanGDP, whereas the GDP (guanosine diphosphate) on 
RanGDP will be exchanged for a GTP (guanosine triphosphate) in the nucleus by the 
guanine nucleotide exchange factor (RanGEF) (Cavazza and Vernos, 2015). The fact 
that RanGAP and RanGEF (also known as RCC1) are strictly located in different 
compartments leads to a high concentration of RanGTP in the nucleus and a high 
concentration of RanGDP in the cytoplasm (Görlich et al., 2003). It is the gradient 
difference of RanGTP and RanGDP between the two compartments that determines 
where importins and exportins bind or release their cargos. After an importin-cargo 
complex enters the nucleus through the NPC, RanGTP, which has high affinity for 
importins, binds tightly to the importin. The binding of RanGTP causes a conformational 
change in the importin that lowers its affinity for and displaces the cargo. The RanGTP-
importin complex then translocates back to the cytoplasm, where GTPase is activated 
and RanGTP is hydrolyzed to RanGDP. The switch from RanGTP to RanGDP drastically 
decreases Ran’s affinity for importins. Therefore, the importin is released and starts the 
next round of cargo import. On the other hand, the export pathway regulated by the Ran 
system is rather different, or even opposite. In contrast to the importin pathway, exportins 
bind cargo after binding RanGTP and displace cargo when RanGDP-bound.  
The Nucleocytoplasmic Transport Pathway of TR 
From the “shuttle” karyopherins to the “cargo” TR that regulates TH genomic 
function, all the machinery that is involved in the process of TR nucleocytoplasmic 
transport has now been introduced. Figure 5 illustrates the entire nucleocytoplasmic 
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transport pathway of TR. The story starts with a cytoplasmic TR that needs to be imported 
into the nucleus. Under a high RanGDP concentration, TR binds to specific importins with 
high affinity. Two possible binding products might occur: a classical NLS directed TR-
IPOα1-IPOβ1 complex or a nonclassical NLS directed TR-β family importin complex. Both 
complexes interact with the FG repeats on the cytoplasmic filaments of NPC embedded 
in the nuclear envelope. The TR-importin complex passes through the NPC and 
translocates into the nucleus where there is a high concentration of RanGTP. RanGTP 
then binds to the importin in the complex, causing a conformational change that lowers 
importin’s affinity for TR. Subsequently, TR is released in the nucleus and represses 
target gene transcription by forming homodimers or heterodimers when TH is absent.  
The importin-RanGTP complex will then exit through the NPC. The hydrolysis of 
RanGTP is activated shortly after the importin-RanGTP complex interacts with the 
RanGAP associated with cytoplasmic nucleoporins. RanGDP no longer occupies the 
importin, allowing the free importin to start another round of TR nuclear import. In order 
to maintain a high nuclear RanGTP concentration, presumably all RanGDP molecules 
need to be transported back to the nucleus for RanGTP conversion. A different 
transporter called nuclear transport factor 2 (NTF2) delivers RanGDP into the nucleus, 
where RanGDP is converted to RanGTP by RanGEF.  
Since TR shuttles between the nucleus and cytoplasm, some TR eventually will be 
sent back to the cytoplasm through the NPC by specific exportins. The high concentration 
of nuclear RanGTP increases exportins’ affinity for any free TR. TR bound exportin 
interacts with the FG-repeats of certain nucleoporins on the nuclear side of the NPC 
(Askjaer et al., 1999), which allows the TR-exportin complex to pass through the NPC  
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Figure 5. TRα1 nucleocytoplasmic transport pathway. TR binds to specific 
importins under a high RanGDP concentration. The TR-importin complex passes through 
the NPC and translocates into the nucleus where there is a high concentration of 
RanGTP. RanGTP then binds to the importin, causing a conformational change that 
lowers importin’s affinity for TR. The new dual importin-RanGTP complex will exit through 
the NPC. The hydrolysis of RanGTP causes importin dissociation, allowing the free 
importin to start another round of TR nuclear import. Nuclear transport factor 2 (NTF2) 
delivers RanGDP into the nucleus, where RanGDP is converted to RanGTP by RanGEF. 
Free TR will be sent back to the cytoplasm by specific exportins. 
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and translocate to the cytoplasm. Finally, the exportin dissociates from the TR due to its 
decreased affinity under high cytoplasmic RanGDP concentration, allowing the free TR 
to enter the next cycle of nucleocytoplasmic transport. Although the overall pathway is 
clear, many aspects of the mechanism still need to be explored. For example, among all 
the 20 characterized karyopherins, which importin(s) and exportin(s) are responsible for 
TR’s nucleocytoplasmic transport? Furthermore, since TRα1 has multiple NLSs and 
NESs, which ones are recognized by which specific importin(s) or exportin(s), 
respectively? The story of TR nucleocytoplasmic transport pathway cannot be fully 
understood without these missing pieces. 
 
What’s Known and Unknown 
 Ever since TRα1 was discovered to undergo nucleocytoplasmic shuttling, using a 
signal-mediated pathway in mammalian cells (Bunn et al., 2001), researchers started 
paying more attention to the TRα1 transport mechanism. TRα1 nucleocytoplasmic 
shuttling requires energy, physiological temperature, and soluble factors (Grespin et al., 
2008; Roggero et al., 2016). Due to the large number of characterized karyopherins and 
the evidence that they have overlapping cargo sets, a detailed investigation of which of 
the importins/exportins are used to import or export TRα1 is crucial for a greater 
understanding of the TRα1 nucleocytoplasmic transport mechanism. Previous studies 
have targeted the possible importins and exportins that are involved in the transport of 
TRα1, including the use of both IPOβ1/IPOα1-mediated classical pathways and other 
importin-mediated non-classical import pathways (Mavinakere et al., 2012; Roggero et 
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al., 2016), as well as the use of both CRM1/calreticulin mediated and other exportin-
mediated export pathways (Grespin et al., 2008; Subramanian et al., 2015). However, all 
these possible candidates could not be confirmed without evidence of direct, physical 
protein-protein interaction between them and TRα1. Chapter 3 of this thesis presents our 
recently published article (Roggero et al., 2016) that provides an in-depth explanation of 
how those interactions were determined. Since this thesis mainly focuses on TRα1 
nuclear import, the additional work done for the exportins is presented in Chapter 5. 
Therefore, the first question that is addressed in this thesis is which importins, when 
down-regulated by RNAi, have a strong impact on TRα1 nuclear localization in vivo, and 
also interact with TRα1 directly in coimmunoprecipitation assays.  
 As mentioned earlier in the introduction, two NLSs have been identified in TRα1 
so far. The first classical bipartite NLS, named NLS-1, is located in the hinge region (Bunn 
et al., 2001; Mavinakere et al., 2012). The overall basic amino acid sequence 
KRVAKRKLIEQNRERRRK (Lysine-Arginine-Valine-Alanine-Lysine-Arginine-Lysine-
Leucine-Isoleucine-Glutamic Acid-Glutamine-Asparagine-Arginine-Glutamic Acid-
Arginine-Arginine-Arginine-Lysine) meets with the requirement for interacting with 
karyopherins. Mavinakere et al.’s work in 2012 demonstrated that NLS-1 is sufficient to 
import the G3 protein (a cytoplasmic-localized fusion protein consisting of GFP-GST-
GFP) into the nucleus when G3 is fused with the hinge region. This classical bipartite 
NLS-1 is conserved in TRβ1. Since NLS-1 is classical, it’s logical to predict that the 
IPOβ1-IPOα1 heterodimer mediates nuclear import. However, there is a high possibility 
that other β-family importins could take part in the import process as well. On the other 
hand, NLS-1 in the hinge region was shown to only partially target TRα1 into the nucleus 
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(Picard and Yamamoto, 1987), indicating the existence of a second NLS. With the help 
of the program PSORT II (Nakai and Horton, 1999), Mavinakere et al. (2012) identified 
the second NLS (NLS-2) located in the A/B domain. They performed the same experiment 
in which G3 was fused with either TRα1’s or TR β1’s A/B domain to examine if there were 
sufficient sequences to target the cytoplasmic protein into the nucleus. The result showed 
a non-classical, novel, and monopartite 8-amino acid sequence PDGKRKRK that only 
exists in TRα1, not in TRβ1, that successfully targets G3 into the nucleus. This points to 
the possibility of TRα1 using multiple importins other than the classical import pathway. 
At the same time, studying which importin recognizes which NLS also helps to gain a 
better knowledge of the TRα1 import mechanism. Therefore, the second research 
question addressed in this thesis is which importins interact with TRα1’s NLSs. 
 
RNA Interference-Induced Importin Knockdown 
 RNAi is one of the most important discoveries in biology over the past decade. It 
totally changed how scientists value RNA as a regulatory molecule, as opposed to simply 
an information carrier. Researchers found out that RNA-induced RNAi is a process of 
down-regulating mRNA expression, therefore consequently knocking down the 
corresponding proteins. If that is not impressive enough, this mechanism has become the 
heart of scientific research as well as medical treatment of certain diseases. But who 
would have ever thought this revolution all started with cultivating a purple petunia. In 
1986, Dr. Richard Jorgensen was asked to create a dazzling flower to attract investors. 
Since the genetic engineering techniques in 1986 were lacking in sophistication, the 
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experiment was done in petunia which was easier to introduce genes into at the time. 
Jorgensen and coworkers attempted to make a very purple petunia by introducing more 
copies of the purple pigment gene. Logically, the flowers would be more purple, but 
instead they harvested white flowers with no purple pigmentation. This completely 
unexpected result caused a huge debate in the scientific field. Scientists tried to map out 
the mechanism by working on different organisms, but it wasn’t understood until 1998.  
In 1998, Dr. Craig Mello and Dr. Andrew Fire discovered an interesting 
phenomenon when they were studying the C. elegans muscle protein unc-22. After they 
injected unc-22 double stranded RNA (dsRNA) into C. elegans, the unc-22 gene was 
specifically silenced which lead to decreased unc-22 production. This phenotype caused 
by the dsRNA precisely mimicked the unc-22 mutations (Fire et al., 1998). What was 
realized by this discovery is that scientists would be able to artificially silence specific 
genes without mutating the DNA sequence. Furthermore, the post-translational silencing 
effects could be passed on to the next generation. Fire and Mello named this mechanism 
RNAi. For this amazing discovery, they were awarded the Nobel Prize in Medicine at 
2006. So, how does RNAi interfere with protein production and how was it used in our 
TRα1 nuclear import research? 
Soon after 1998, many laboratories began developing strategies to silence genes 
by triggering RNAi, either through introducing long dsRNA or constructing plasmids that 
encode the small interfering RNA (siRNA) of interest (Clemens et al., 2000). However, 
the problem was that not only were those strategies not efficient in mammalian cells but 
they also triggered innate immune responses (Stark et al., 1998). Ever since the discovery 
that RNAi is triggered by 21 nucleotide RNAs with phosphorylated 5’ ends and 
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hydroxylated 3’ ends was reported (Elbashir et al., 2001), introducing 21 base pair 
dsRNAs to knockdown gene expression has become practical (Zamore et al., 2000). This 
technique was demonstrated to be efficient in both mammalian cells and Drosophila 
without causing innate immune responses (Elbashir, et al., 2001). Now, two ways to 
trigger RNAi are widely used, introducing dsRNAs directly or plasmid vectors that encode 
short hairpin RNAs (shRNA) which are eventually processed to siRNAs. Either way, 
selecting a siRNA that has the highest knockdown potency among a few designed 
siRNAs ensures the siRNA’s specificity towards the target mRNA. The most important 
benefit of using plasmid vectors to introduce dsRNA is that it maintains high siRNA levels 
for a long period of time in the cells, since siRNA degrades more quickly (Grimm, 2009).  
Of relevance to this thesis research, the half-life of importins is typically 12 hours, 
which indicates the requirement of a long term supply of siRNA. In this thesis, all importin 
knockdown experiments were conducted by introducing shRNA plasmid sets into HeLa 
cells using a lipid-based transfection reagent called Lipofectamine 2000. These positively 
charged lipid molecules are attracted to the negatively charged plasmids to form 
liposomes which fuse with the plasma membrane and allow plasmids to enter the cell. 
The plasmids then enter the nucleus by an unknown mechanism and are transcribed to 
dsRNAs with short hairpins by utilizing the cell’s RNA polymerase II system. Shortly after 
being transcribed, dsRNAs are exported out of the nucleus through NPCs. When dsRNA 
or shRNA locates in the cytoplasm, it is cut by the protein Dicer into a siRNA. The siRNA 
then interacts with the RNA-induced silencing complex (RISC). RISC is activated after 
incorporating with one of the two RNA strands, whereas the other strand is degraded. 
The activated RISC-single strand RNA complex binds with complementary target mRNA 
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and cleaves it through action of the endonuclease Slicer. Consequently, the loss of mRNA 
directly suppresses target protein translation.  
RISC is the heart of the entire RNAi-induced knockdown pathway. It has many 
critical functions, such as recognizing siRNA, unwinding siRNA, incorporating with the 
template RNA strand, and cutting the target mRNA strand. All those jobs are done by a 
group of proteins called Argonaute proteins (AGO). Among the 8 human AGO proteins, 
only AGO2 assists the silencing process (Hutvagner and Simard, 2008). AGO2 has three 
domains, Piwi-Argonaute-Zwille (PAZ) domain, middle (MID) domain, and PIWI domain, 
each of them possesses specific duties. The 5’ monophosphate group of the template 
strand tucks in between the PIWI and MID domains, whereas the PAZ domain recognizes 
the 3’ dinucleotide end. This orientation allows the PIWI domain, which has an RNase H 
fold, to cut the target mRNA strand by base pairing to the “seed region” of the template 
strand (Liu et al., 2004; Song et al., 2004).  
After going through this RNAi-induced knockdown process, in the experiments 
presented in this thesis, each endogenous importin was partially depleted individually due 
to the lack of corresponding mRNA and its impact on TRα1’s nuclear import could then 
be tested. Figure 6 illustrates the procedure of RNAi-induced protein knockdown. 
Although RNAi’s popularity was gained from its specificity, some nonspecific off-target 
effects have been reported. Due to shRNAs’ similarities with microRNAs (miRNA), 
unintended RNAi could happen via shRNA causing miRNA-like binding in the 3’ UTRs 
(Birmingham et al., 2006). Moreover, since both shRNA and miRNA are exported by 
exportin 5 (XPO 5), long term expression of shRNA could compete with miRNA, which 
causes saturation and represses the natural miRNA machinery (Wang et al., 2011). 
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Figure 6. RNAi induced protein knockdown mechanism. A brief illustration 
of RNAi induced protein knockdown used in this thesis research. shRNA plasmids are 
introduced to HeLa cells. After shRNA is transcribed, it gets exported into the cytoplasm 
where DICER cuts it to siRNA. RISC complex unwinds and separates siRNA. The 
activated RISC-single strand RNA complex will bind with complementary target mRNA 
and cut it into small pieces. Consequently, the loss of mRNA directly suppresses target 
protein translation. 
 
 
 
 
 
interfering 
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Chapter 2: Materials and Methods 
RNA interference 
Pre-designed SureSilencing™ shRNA plasmid sets, including plasmids of a 
scrambled negative control, IPOβ1, IPOα1, IPO4, IPO5, IPO7, IPO8, IPO9, IPO11, and 
IPO13 were used to knockdown importins. Each of the sets came with four types of target-
specific plasmids (named as “Red”, “Yellow”, “Blue”, and “Green”) that can produce 
functional designed siRNAs. Instead of selecting the one that has the highest knockdown 
potency, we adjusted the concentrations of the four types to the same level (1 g/1l) and 
combined them together for transfection. 
 
Transient Transfection and Fluorescence Microscopy 
 Human (HeLa, ATTC CCL-2) cells were used as the model system. They were 
cultured in Minimum Essential Medium (MEM) supplemented with 10% fetal bovine serum 
(FBS) (Life Technologies) at 37oC under 5% CO2 and 98% humidity. Twenty-four hours 
before transfecting HeLa cells with importin shRNA coded plasmids, as well as GFP-
tagged TRα1 plasmids, cells were seeded on 22mm coverslips in 6-well culture dishes at 
a density of 2.2 x 105 cells per well with fresh MEM containing 10% FBS. Since 
experiments were performed in 6-well culture dishes, three different treatments could be 
tested in every trial with two technical replicates for each. The three treatments were 
negative control (1 g scrambled sequence shRNA plasmid + 1 g GFP-TRα1 expression 
plasmid), TRα1-only control (1 g GFP-TRα1 expression plasmid only), and experimental 
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group (1 g appropriate importin shRNA plasmid + 1 g GFP-TRα1 expression plasmid). 
All the plasmids were contained in 2ml MEM supplemented with 10% FBS along with 3 
l Lipofectamine 2000 (Invitrogen). Right before the transfection, cells were washed with 
1x Dulbecco’s phosphate buffered saline (1x DPBS). 8 hours after transfection, the 
transfection media was replaced with 2 ml fresh MEM supplemented with 10% FBS. 26-
hours post-transfection, cells were washed with 1x DPBS three times, and fixed in 3.7% 
formaldehyde for 7 min. The fixation was followed by three more washes (5 min each 
time) with 1x DPBS. The last step was to mount the coverslips on microscope slides using 
8 l Fluoro-Gel II containing DAPI (0.5 g/ml). The slides were analyzed by fluorescence 
microscopy to determine the localization pattern of GFP-TRα1. 
 Each slide was viewed under fluorescence microscopy and 200 cells were scored 
into three categories (Figure 7) based on the overall localization pattern of fluorescence 
(performed blind). The first category was nuclear only (N). Cells in this category showed 
an almost completely nuclear localization pattern of GFP-TRα1. The second category 
was nuclear greater than cytoplasmic (N>C). Cells of this category still showed a strong 
nuclear fluorescence but there was also a distinct cytoplasmic fluorescence pattern. As 
long as the nucleus still could be distinguished from the cytoplasm through the bright edge 
of the nuclear envelope, the cell was put into this group. The last category was whole cell 
(N=C). The fluorescence localization of cells in this group was spread out; the nucleus 
could not be distinguished from the cytoplasm due to the even distribution of 
fluorescence. At least three independent, biologically separated replicates (with 2 
technical replicates each) were included in the Microsoft Excel data analysis. 
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Figure 7. Scoring categories for TRα1 localization.  
GFP-TRα1 localization pattern was scored as one of the three categories: cells that 
showed almost complete nuclear localization pattern of GFP-TRα1 were categorized as 
nuclear only (N); cells that had a nuclear GFP-TRα1 localization and less intense 
cytoplasmic distribution were categorized as nuclear greater than cytoplasmic (N>C); 
cells that had almost equal GFP-TRα1 distribution among the nucleus and cytoplasm 
were categorized as whole cell (N=C). 
 
                    GFP                         DAPI                     Merge 
N 
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Western Blotting (Immunoblotting) 
 To ensure that any visualized GFP-TRα1 localization change was directly linked 
to the decrease of an importin, the knockdown efficiency needed to be confirmed. 
Therefore, the second major approach used in this thesis to test importin knockdown 
efficiency was immunoblotting, or Western Blotting (WB) (Figure 8). Western Blotting has 
been widely used to detect specific proteins from cell extracts. The results of 
chemiluminescent detection show up on exposed X-ray films as dark bands that have 
different densities. According to the presence and the density of a band, WB generally 
answers two questions: 1) is the targeted protein expressed or present? and 2) is the 
expression of the targeted protein in a treatment group increased or decreased relative 
to a control? Clearly, the first question could be answered by checking if a band was 
present, whereas the second question is answered by comparing the densities of different 
bands under different treatments.  
 The first step here, was to knockdown the targeted importin by transfecting HeLa 
cells with the desired shRNA plasmid. Cells were seeded in 100 mm vented plates at a 
concentration of 9 x 105 cells per plate and transfected with 10g plasmid DNA. All 
conditions including temperature (37oC), CO2 (5%), humidity (98%), and incubation timing 
were kept the same as for the 6-well plate transfection described above. eight h post-
transfection, the transfection medium was replaced with fresh MEM containing 10% FBS. 
Cell lysates were extracted after 26 h of transfection. Protein concentration was estimated 
by a NanoDrop® ND-1000 full-spectrum UV/Vis Spectrophotometer both to prevent 
protein over-load and ensure the same amount of protein was used. SDS-PAGE sample 
buffer was then added to lysate samples and they were boiled for 10 min to denature the  
46 
 
 
 
Figure 8. Western blotting. Cell protein lysate is extracted before loading the same 
amount of protein to each lane for SDS-PAGE. Proteins are separated based on their 
sizes after running at 150 volts for 45 min. Proteins are then transferred from the 
polyacrylamide gel to a special PDVF membrane with the same separation pattern. Then, 
the membrane is incubated with primary antibody and secondary antibody respectively 
with washes in between. After a chemiluminescent incubation step, the membrane is 
exposed to an X-ray film. 
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proteins (Algenäs et al., 2014). During denaturation, proteins are not only linearized but 
also negatively charged due to sodium dodecyl sulfate (SDS). This process ensures that 
proteins migrate towards the positive electrode. After the proteins were separated based 
on their sizes (shorter amino acid sequences run faster), they were transferred from the 
polyacrylamide gel to a special PVDF membrane with the same separation pattern. Then, 
the membrane was incubated with, for example, anti-IPO7 primary antibody and anti-
rabbit secondary antibody, with washes (0.1 M Tris–HCl, 0.5 M NaCl, 0.1% Tween) in 
between. The secondary antibody is linked to Horseradish Peroxidase (HRP). After 
adding in the chemiluminescent substrate, the position that locates the importin band will 
show chemiluminescence due to the substrates’ oxidation by HRP. The last step is to 
expose the membrane to an X-ray film in the dark room. If the target importin, for example 
IPO7, was expressed in the cells, then an exposed dark band was found on the film. 
Using NIH ImageJ software to perform densitometry on a scanned film, the densities of 
the IPO7 bands under different treatments could be measured as digital data for EXCEL 
input and compared for the fold difference.  
 Therefore, if the knockdown importin band’s density was significantly lighter than 
the band from no treatment, while the loading control GAPDH (Glyceraldehyde 3-
phosphate dehydrogenase) bands of both groups had a similar density, then the importin 
knockdown was efficient. In order to have non-overexpressed bands on X-ray films, 
multiple exposure times (e.g., 10 sec, 30 sec, 2 min) were taken for each trial and the 
best-exposed result was picked for publication. Meanwhile, an appropriate dilution of both 
primary and secondary antibodies was critical both to prevent extra signal which causes 
background subtraction and to ensure the interaction between antigen and antibody was 
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specific. The concentration of antibodies used in this thesis were as follows: anti-IPOβ1 
(Santa Cruz), 1:2000; anti-IPOα1 (Santa Cruz), 1:2000; anti-IPO4 (Santa Cruz), 1:333; 
anti-IPO5 (Santa Cruz), 1: 10,000; anti-IPO7 (Abcam, Cambridge, MA), 1:1000; anti-IPO8 
(Abcam), 1:250; anti-IPO9 (Abcam), 1:250; anti-IPO11 (Abcam), 1:333; anti-IPO13 
(Santa Cruz), 1:100; anti-GAPDH (Santa Cruz Biotechnology Inc, Dallas, TX), 1:5000; 
horseradish peroxidase (HRP)-conjugated donkey anti-rabbit IgG (GE Healthcare Life 
Sciences), 1:25,000; HRP-sheep anti-mouse IgG (GE Healthcare Life Sciences), 
1:25,000. Pre-Stained Kaleidoscope Protein Standards (Bio-Rad, Hercules, CA) were 
used as the ladder to confirm protein sizes. At least 3 knockdown replicates were 
performed for each importin.  
 
GFP-Trap Coimmunoprecipitation 
 When a research question asks whether one protein has influence on another, the 
final step always comes down to showing their physical interaction. Scientists have thus 
developed many technologies to this end, including yeast two-hybrid, Tandem affinity 
purification, Bimolecular fluorescence complementation, and the one that played a central 
role in this thesis, coimmunoprecipitation (CoIP). CoIP has been considered as the gold 
standard assay for testing protein physical interactions. Its benefits include that it is 
relatively easily performed, can be tested with endogenous proteins, and is highly specific 
due to antibody selection. The standard procedure of CoIP (Figure 9) contains three 
steps: first, proteins are extracted from the cells (cell lysate preparation); second, the 
protein of interest gets isolated by the specific antibody (IP); third, proteins interacting  
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Figure 9. “GFP-trap” coimmunoprecipitation. Proteins are extracted from the 
cells. After being washed with 1 X DPBS several times, the protein extract is incubated 
with anti-GFP antibody embedded agarose beads. Proteins that are tagged with GFP will 
be trapped by the agarose beads, and the proteins of interest are coimmunoprecipitated. 
Elution buffer is used to elute the proteins from the beads and identify the protein of 
interest with Western blotting. 
 
 
 
 
lyse the cells 
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with the protein of interest are identified by WB (binding partner identification). The CoIP 
procedure used in this thesis is called “GFP-trap”. Recall that the protein of interest, TRα1, 
is tagged with GFP. When a cell lysate containing GFP-TRα1 is incubated with anti-GFP 
antibody embedded agarose beads, GFP-TRα1 will be “trapped” by the agarose beads. 
After a couple of washes with the dilution/washing buffer (2mM Tris-HCl, pH7.5, 30 mM 
NaCl, 0.1mM EDTA), proteins that could not bind with the beads are washed off, and 
GFP-TRα1 is specifically separated. Meanwhile, any proteins interacting with the TRα1 
portion of the fusion protein would be subsequently “trapped” or coimmunoprecipitated. 
Finally, western blotting is performed to identify the importins that had interactions with 
GFP-TRα1.  
 Since the “GFP-trap” CoIP was one of the most important methods developed in 
this thesis as a new technique in the Allison lab, a detailed step-by-step explanation is 
provided. GFP-trap CoIP starts with transfecting HeLa cells with GFP-TRα1 expression 
plasmids. Cells were seeded at a concentration of at least 9×105 cells per 100mm plate. 
24 hours after seeding, cells were transfected with 10 g GFP-TRα1 expression plasmids 
with 20 l Lipofectamine 2000. The transfection media was replaced with fresh MEM 
containing 10% fetal bovine serum after 8 h post-transfection. 26 h post-transfection, the 
transfection efficiency was determined by ZOE image analysis. The following GFP-trap 
procedure only continued when at least 80% of the cells were successfully transfected 
and healthy. The plates were brought back to the tissue culture hood and rinsed once 
with 10 ml of 1x DPBS. Cells were treated with 0.7 ml of 0.25% trypsin (Life Technologies) 
for no longer than 3 min, and then collected in 1.0 ml MEM supplemented with 10% FBS. 
After being transferred to 2.0 ml microcentrifuge tubes, cells were washed twice with 
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centrifugation at 1000rpm, room temperature for 1 minute between washes. The washed 
cells were incubated on ice for 30 min with 200 µl of Lysis Buffer (10 mM Tris-HCl, pH 
7.2, 150 mM NaCl, 0.5 mM EDTA) containing 0.5% IGEPALR (NP-40 equivalent, Sigma-
Aldrich) and 2 µl 100X Halt Protease Inhibitor Cocktail (Thermo Scientific). The lysate 
was mixed through pipetting every 10 min. After the 30 min of incubation, the lysate was 
cleared by centrifugation at 4°C, 16,000 x g for 10 min, and the supernatant was 
transferred to a pre-cooled 1.5ml microcentrifuge tube and diluted with 300 µl of 
dilution/washing buffer containing 3 µl 100X Halt Protease Inhibitor Cocktail, to yield a 
final concentration of 0.2% IGEPAL. During the 30 min, 15 µl GFP-trap agarose beads 
(GFP-TrapR_A, Chromotek GmbH, Planegg-Martinsried, Germany) were pre-equilibrated 
by washing three times with 500 µl Dilution/Washing Buffer in the uncapped filtration 
column, centrifuged at 4°C, 3000xg for 1 min between washes. A tip here is that agarose 
beads are concentrated at the bottom of the container. Therefore, to extract the same 
amount of beads for each sample, the bead slurry needs to be mixed completely by 
tapping the container. The next step was to add the diluted supernatant into the capped 
filtration columns, followed by a 2 h incubation in the 4°C cold room with end-over-end 
rotation. After the incubation, the uncapped filtration columns were centrifuged at 4°C, 
3000 x g for 1 min, and a 60 µl sample of the flow-through was collected labeled as 
“unbound” and resuspended with an equal volume of 2X Sample Buffer (2% SDS, 10% 
glycerol, 250 mM Tris-HCl, pH 6.8, 0.01% bromophenol blue, 20 mM DTT). The beads in 
the uncapped filtration columns were washed 4 times with 500 µl dilution/washing buffer 
and centrifuged at 4°C, 3000xg for 1 min between washes. The last step was to dissociate 
the “trapped proteins” from the beads. 50 µl 0.2 M glycine, pH 2.5, was added to the 
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columns and incubated with the beads for 5 min followed by centrifugation at 4°C, 3000 
x g for 1 min. Proteins that bound to GFP-TRα1 would be eluted to a new set of tubes 
labeled as “bound”. To neutralize the extremely acidic elution buffer, 5 µl 1M Tris base 
pH 10.4 was added to the final “bound” products. After adding 65 µl of 2X SDS Sample 
Buffer, the “bound” samples, along with the “unbound” samples, were analyzed by WB. 
The importins tested by GFP-trap were IPOα1, IPOβ1, and IPO7, due to the fact that their 
knockdown results showed significant TRα1 localization change. Among the rest of the 
importins that showed no impact on TRα1 localization, IPO4 was chosen as the negative 
control. A GFP transfected cell group was also included as a negative control to test for 
any nonspecific trapping. Antibodies were used at the following concentrations: anti-GFP 
(Santa Cruz), 1:2000; anti-IPO4 (Abcam), 1:1250; anti-IPOα1 (Abcam), 1:1000; anti-
IPOβ1 (Santa Cruz), 1:1000; anti-IPO7 (Abcam), 1:1000; HRP-conjugated donkey anti-
rabbit IgG (GE Healthcare Life Sciences), 1: 25,000. 
 GFP-trap coimmunoprecipitation helped to confirm the physical interactions 
between TRα1 and the importins that are responsible for its nuclear transport. As for the 
second research question, the same coimmunoprecipitation was performed but with the 
segments of TRα1 that contained either NLS1 or NLS2 to test which one of them 
recognizes which importin. Chapter 3 is the published paper that presents all the results. 
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Abstract 
The thyroid hormone receptor 1 (TR1) is a nuclear receptor for thyroid hormone 
that shuttles rapidly between the nucleus and cytoplasm. Our prior studies showed that 
nuclear import of TR1 is directed by two nuclear localization signals, one in the N-
terminal A/B domain and the other in the hinge domain. Here, we showed using in vitro 
nuclear import assays that TR1 nuclear localization is temperature and energy-
dependent and can be reconstituted by the addition of cytosol. In HeLa cells expressing 
green fluorescent protein (GFP)-tagged TR1, knockdown of importin7, importin1 and 
importin1 by RNA interference, or treatment with an importin1-specific inhibitor, 
significantly reduced nuclear localization of TR1, while knockdown of other importins 
had no effect. Coimmunoprecipitation assays confirmed that TR1 interacts with importin 
7, as well as importin1 and the adapter importin1, suggesting that TR1 trafficking into 
the nucleus is mediated by two distinct pathways. 
 
Abbreviations 
The abbreviations used are: TRα1, thyroid hormone receptor α1; TRα1, thyroid 
hormone receptor α1; NPCs, nuclear pore complexes; NLS, nuclear localization signal; 
RNAi, RNA interference; GFP, green fluorescent protein; GST, Glutathione-S-
transferase; shRNA, short hairpin RNA; RT-qPCR, real-time quantitative PCR; FITC, 
fluorescein isothiocyanate; RRL, rabbit reticulocyte lysate; TRE, thyroid hormone 
response element; T3, 3,3′,5-triiodo-L-thyronine (thyroid hormone). 
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Introduction 
The thyroid hormone receptor α1 (TRα1) is a transcription factor in the nuclear 
receptor superfamily that either activates or represses transcription of thyroid hormone-
responsive genes, depending on its liganded state. TRα1 carries out its function through 
binding target genes in the nucleus; however, our previous research has shown that TRα1 
shuttles back and forth between the nucleus and the cytoplasm (Bunn et al., 2001; 
Grespin et al., 2008). An important aspect of nucleocytoplasmic shuttling, and for the role 
of TRα1 as a transcription factor, is the process by which TRα1 is imported into the 
nucleus from the cytoplasm by crossing the nuclear envelope. The nuclear envelope 
creates an intracellular compartment that enables spatial regulation of gene expression 
and plays a key role in signal transduction pathways, in gene activation or repression, 
and in the regulation of major cellular processes (Lange et al., 2010; Sekimoto and 
Yoneda, 2012; Stewart, 2007; Tran et al., 2014). 
Nuclear proteins cross the nuclear envelope via large protein assemblages 
approximately 100 MDa in size called nuclear pore complexes (NPCs) (Adams and 
Wente, 2013). Nuclear import of small molecules, including small proteins (less than 40 
kDa), can occur by passive diffusion through the central channel of the NPCs; however, 
in most cases, both small and large proteins enter the nucleus by an energy-dependent, 
signal-mediated pathway (Gorlich and Kutay, 1999; Gorlich and Mattaj, 1996; Grossman 
et al., 2012; Stewart, 2007; Tetenbaum-Novatt and Rout, 2010). Signal-mediated 
transport requires soluble factors collectively called karyopherins, or importins, to facilitate 
translocation into the nucleus (Pemberton and Paschal, 2005; Sekimoto and Yoneda, 
2012; Stewart, 2007), and also relies on an asymmetrical cellular distribution of the small 
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GTPase Ran in either its GTP or GDP bound state. A high nuclear RanGTP concentration 
is required for dissociation of import complexes that have successfully passed through 
the NPC (Fried and Kutay, 2003; Gorlich et al., 1997; Gorlich et al., 1996; Tetenbaum-
Novatt and Rout, 2010; Wente and Rout, 2010). Adding to the complexity of mechanisms 
for nuclear entry, a recent report suggests that an importin-dependent nuclear import 
pathway can be accessed by proteins with conserved ankyrin repeats (Lu et al., 2014). 
Importins bind to a cargo protein by recognizing a short lysine or arginine-rich amino acid 
motif on the cargo protein known as a nuclear localization signal (NLS). Two NLSs in 
TRα1 have been fully characterized: NLS-1, a classical bipartite NLS in the hinge region 
(Baumann et al., 2001; Casas et al., 2006; Lee and Mahdavi, 1993; Maruvada et al., 
2003; Mavinakere et al., 2012; Zhu et al., 1998) and, more recently, NLS-2, a novel, 
monopartite NLS in the N-terminal A/B domain (Mavinakere et al., 2012). 
 The karyopherin-β family is responsible for the majority of nuclear transport 
pathways, with each member performing a distinct nuclear import, export, or bi-directional 
transport function (Cook et al., 2007; Macara, 2001; Strom and Weis, 2001; Xu et al., 
2010). Members of this family involved in nuclear import are characterized by their ability 
to either bind NLS-bearing cargo directly or indirectly via an adaptor importin (Cingolani 
et al., 2002; Lott and Cingolani, 2011; Palmeri and Malim, 1999). Importinβ1 is the best-
studied member of the karyopherin-β1 family, which includes 10 other known family 
members that can mediate import of proteins into the nucleus (Lange et al., 2007; 
Mosammaparast and Pemberton, 2004; Pemberton and Paschal, 2005; Stewart, 2007; 
Strom and Weis, 2001). Most nuclear import occurs via direct binding of a karyopherin-β 
receptor to a cargo protein. In the classical nuclear import model, however, importinα acts 
58 
 
as an adaptor protein that recognizes and binds to a specific NLS motif on the cargo, and 
then binds importinα1 (Lange et al., 2007; Riddick and Macara, 2005, 2007). The human 
genome encodes at least six importinα isoforms: α1, α3, α4, α5, α6, and α7 (Friedrich et 
al., 2006). Each importinα isoform is responsible for binding to and facilitating import of 
several different cargo proteins in conjunction with importinβ1 (Cook et al., 2007; Goldfarb 
et al., 2004; Lange et al., 2010; Lange et al., 2007). 
 In the present study, we sought to characterize the general mechanism for TRα1 
transport, using in vitro nuclear import assays. Additionally, we used RNA interference 
(RNAi), treatment with importazole, an importinβ1-specific inhibitor, and 
coimmunoprecipitation assays in HeLa cells to identify which importins mediate nuclear 
import of TRα1. Taken together, our in vitro and in vivo data suggest that TRα1 can follow 
two distinct temperature and energy-dependent, signal-mediated import pathways, with 
importin7, importinβ1, and the adapter importinα1 acting as major players in localizing 
TRα1 to the nucleus. 
 
Methods 
Plasmids and recombinant proteins 
pGFP-TRα1 is an expression plasmid for functional green fluorescent protein 
(GFP)-tagged rat TRα1 (Bunn et al., 2001), and the expression vector for enhanced GFP, 
EGFP-C1, was obtained from Clontech Laboratories, Inc. (Mountain View, CA). The 
plasmid GFP-TRα1 encodes GFP-tagged human TRα1 (Mavinakere et al., 2012).  The 
GFP-Glutathione-S-transferase (GST)-GFP (G3) expression vector, G3- A/BD 
59 
 
(containing NLS-2) expression plasmid, and G3-Hinge (containing NLS-1) expression 
plasmid were previously described (Mavinakere et al., 2012). The plasmid hTERT-GFP 
was a gift from R. H. Kehlenbach (University of Göttingen) and encodes GFP-tagged 
human telomerase reverse transcriptase (Frohnert et al., 2014). pGST-GFP-NLS was a 
gift from R. J.G. Haché (University of Ottawa) and expresses a fusion protein comprised 
of GST and GFP with the sequence of the simian virus 40 (SV40) T-antigen NLS 
(PKKKRKV) at the C terminus (Walther et al., 2003). pGEX-2T-T3Rα was a gift from M. 
Privalsky (University of California) and encodes GST-tagged TRα1 (Tzagarakis-Foster 
and Privalsky, 1998). Pre-designed SureSilencing™ short hairpin RNA (shRNA) plasmid 
sets, consisting of four different shRNA expression plasmids for each target mRNA, were 
purchased from SABioscience (Frederick, MD) for human importinα1 (KPNA2), 
importinα3 (KPNA4), importinα4 (KPNA3), importinα5 (KPNA1), importinα7 (KPNA6), 
importinβ1 (KPNB1), importin4 (IPO4), importin5 (IPO5), importin7 (IPO7), importin8 
(IPO8), importin9 (IPO9), importin11 (IPO11), importin13 (IPO13), and a scrambled 
sequence negative control. The sequences of all shRNAs are provided as supplementary 
information (Table S1). 2xDR4-SV40-Luc was a gift from J. L. Jameson (Northwestern 
University), and consists of two copies of a positive, direct repeat TRE (DR+4) in the firefly 
luciferase vector pGL3. The plasmid pGL4.74 encodes Renilla luciferase (Promega, 
Madison, WI). 
Protein purification and FITC labeling 
Recombinant GST-tagged TRα1 was bacterially expressed and purified by binding 
and elution from Glutathione-Sepharose 4B resin (GE Healthcare Life Sciences, 
Pittsburgh, PA), as described (Grespin et al., 2008). Protein samples were analyzed by 
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8% or 12% SDS-PAGE and protein concentration was estimated using a NanoDrop® ND-
1000 full-spectrum UV/Vis Spectrophotometer. Samples were stored at -80oC. For import 
assays, purified GST-TRα1 was labeled with fluorescein isothiocyanate (FITC) using a 
FluoReporter® Protein Labeling Kit (Life Technologies, Grand Island, NY), according to 
the manufacturer’s instructions. The labeled sample was dialyzed against PBS overnight 
at 4oC, and concentrated using Micron Ultracel YM-30 Centrifugal Filter Devices 
(Millipore, Bedford, MA). Samples were stored at -80oC. 
Permeabilized cell nuclear import assays 
HeLa cells (American Type Culture Collection [ATCC], #CCL-2) were cultured in 
Minimum Essential Medium (MEM) supplemented with 10% fetal bovine serum (FBS) 
(Life Technologies) at 37ºC under 5% CO2 and 98% humidity. HeLa cells were seeded 
on 22 mm Coverslips for Cell Growth™ (Fisher Scientific, Pittsburgh, PA) in 6 well culture 
dishes at a density of 2-3 x 105 cells per well. Sixteen to 24 h hours post-seeding the 
medium in each well was replaced with fresh MEM supplemented with 10% FBS. After 4 
h, cells were washed 2X with 2 ml per well cold Import Buffer (20 mM HEPES, pH 7.3, 
110 mM KOAc, 5 mM NaOAc, 2 mM Mg[OAc]2), then permeabilized with 50 µg/ml 
digitonin (Calbiochem, San Diego, CA) in Import Buffer for 4 min at room temperature. 
Cells were rinsed 1X with 2 ml per well cold Import Buffer for 10 min, and coverslips were 
then inverted over 50 µl drops of Import Reaction Mix (energy regeneration system 
composed of 5 mM creatine phosphate, 20 U/ml creatine phosphokinase, 0.5 mM ATP, 
and 0.5 mM GTP in Import Buffer; 0.67 mM FITC-labeled GST-TRα1; and 25 µl rabbit 
reticulocyte lysate or Import Buffer) on parafilm in a moist chamber for 30 min at 30oC. 
For energy depletion, the energy regeneration system was replaced with apyrase (Grade 
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VIII, 100 U/ml, Sigma-Aldrich, St. Louis, MO). Subsequently, cells were fixed in 3.7% 
formaldehyde (Fisher Scientific) for 10 min, followed by a 5 min wash with Import Buffer. 
Coverslips were mounted on slides with Fluoro-Gel II mounting medium (Electron 
Microscopy Sciences, Hatfield, PA) containing the DNA counter stain 4′,6-diamidino-2′-
phenylindole dihydrochloride (DAPI, 0.5 µg/ml). Cells were analyzed for nuclear 
localization of FITC-GST-TR α1 by fluorescence microscopy. 
Importazole treatment 
HeLa cells were seeded on coverslips in 6 well culture dishes at a density of 2.0-
2.5 x 105 cells per well. Twenty-four hours post-seeding, cells were transfected with 2 µg 
of GFP-TRα1 or GFP-TRα1 expression plasmid using Lipofectamine 2000 (Life 
Technologies). The transfection medium was replaced with fresh MEM containing 10% 
FBS at 5 h post-transfection. Approximately 18 h later, cells were treated for 5 h with 50 
uM importazole (Calbiochem) or an equivalent volume of ethanol (vehicle control). Cells 
were fixed in 3.7% formaldehyde, and coverslips were mounted with Fluoro-Gel II 
containing DAPI (0.5 µg/ml), and then analyzed for the cellular localization of GFP-TRα1 
or GFP-TRα1 by fluorescence microscopy. 
Analysis of nuclear localization by RNA interference (RNAi) 
HeLa cells were seeded on coverslips in 6 well culture dishes at a density of 2.0-
2.5 x 105 cells per well. Twenty-four hours post-seeding, cells were cotransfected with 1 
µg of the appropriate set of four target-specific or control shRNA expression plasmids and 
1 µg GFP-TRα1 expression plasmid using Lipofectamine 2000. The transfection medium 
was replaced with fresh MEM containing 10% FBS at 8 h post-transfection. At exactly 26 
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h post-transfection, cells were fixed and analyzed for the cellular localization of GFP-
TRα1 by fluorescence microscopy. In pilot studies, a range of post-transfection incubation 
times (17 h, 24 h, 26 h, and 30 h) were tested. In addition, we varied the amount of 
Lipofectamine 2000 and the time cells were exposed to the reagent, selected for 
knockdown cells with puromycin, and varied the shRNA plasmid amounts and 
combinations. The conditions described above showed high transfection efficiency (50-
70% of cells were transfected), reduced the levels of importins in cells, and retained cell 
viability. Altered conditions either decreased transfection efficiency, decreased 
knockdown efficiency, or led to increased cell mortality. Cell mortality was assessed by 
visual inspection of the number of adherent cells before and after transfection, with the 
standard set at >60% retention. 
Validation of RNAi by real-time quantitative PCR (RT-qPCR) 
HeLa cells were seeded on 100 mm vented plates at a concentration of 6 x 105 
cells per plate in MEM supplemented with 10% FBS. Twenty-four hours post-seeding, 
each plate was transfected with 10 µg of a set of four target-specific or control shRNA 
expression plasmids using Lipofectamine 2000. The transfection medium was replaced 
with fresh MEM containing 10% FBS at 8 h post-transfection. At exactly 26 h post-
transfection, total RNA was purified using the AurumTM Total RNA Mini Kit (Bio-Rad, 
Hercules, CA), following the Spin Protocol for Cultured Mammalian Cells with a 30 min 
DNase I digestion. Only RNA samples with A260:A280 ratios greater than 2.0 and 
A260:A230 ratios greater than 1.7 were used. RNA quality and integrity was further 
analyzed using an RNA 6000 Pico Total RNA Assay and the Agilent 2100 BioAnalyzer’s 
Lab-on-a-Chip technology (Santa Clara, CA).  
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cDNA was synthesized using SABioscience RT2 First Strand Kit and 0.74 µg total 
RNA. This amount of total RNA was within the manufacturer’s recommended range, and 
was selected to standardize all cDNA synthesis reactions. Samples for real-time 
quantitative PCR (RT-qPCR) were set up in a 48-well plate, using RT2 SYBR 
Green/Fluorescein qPCR Master Mix (SABioscience) and SABioscience validated RT2-
qPCR primers specific for importins7, β1, α1, α3, α4, α5, α7, or glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) as an internal control. No Template controls and No 
Reverse Transcription controls also were included for each sample. Plates were 
centrifuged for 90 sec at 500 xg in a Peqlab PerfectSpin plate spinner (VWR International, 
Radnor, PA), then analyzed using an Applied Biosystems StepOneTM Real-Time PCR 
machine (Life Technologies) as follows: 10 min at 95°C, then 40 cycles of 15 sec at 95°C, 
35 sec at 55°C, and 30 sec at 72°C. SYBR Green fluorescence was detected and 
recorded during the annealing step of each cycle. A melting curve analysis was performed 
as a quality control measure. RT-qPCR data were analyzed by the ΔΔCt (Livak) method 
(Livak and Schmittgen, 2001) using StepOneTM software, and validated by manual 
calculation. 
Validation of RNAi by immunoblotting 
Twenty-six hours’ post-transfection, HeLa cell protein lysates were prepared and 
analyzed by immunoblotting as described (Subramanian et al., 2015). Antibodies were 
used with the following concentrations: anti-GAPDH (Santa Cruz Biotechnology Inc, 
Dallas, TX), 1:5000; anti-importinβ1 (Santa Cruz), 1:2000; anti-importin4 (Santa Cruz), 
1:333; anti-importin5 (Santa Cruz), 1:10,000;  anti-importin7 (Abcam, Cambridge, MA), 
1:1000; anti-importin8 (Abcam), 1:250; anti-importin9 (Abcam), 1:250; anti-importin11 
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(Abcam), 1:333; anti-importin13 (Santa Cruz), 1:100;  anti-importinα1 (Santa Cruz), 
1:2000; anti-importin α3 (Thermo Scientific), 0.2 µg/ml; horseradish peroxidase (HRP)-
conjugated donkey anti-rabbit IgG (GE Healthcare Life Sciences), 1:25,000; HRP-sheep 
anti-mouse IgG (GE Healthcare Life Sciences), 1:25,000; or HRP-mouse anti-goat IgG 
(Santa Cruz Biotechnology), 1:25,000. Protein size was confirmed using Pre-Stained 
Kaleidoscope Protein Standards (Bio-Rad, Hercules, CA). X-ray films were quantified by 
scanning densitometry using NIH ImageJ software. 
Cell scoring by fluorescence microscopy and statistical analysis 
For some analyses an inverted Nikon ECLIPSE TE 2000-E fluorescence 
microscope (Nikon Ultraviolet Excitation: UV-2E/C filter block for DAPI visualization; Blue 
Excitation: B-2E/C filter block for GFP/ FITC visualization) was used with a Nikon Plan 
Apo 40x/0.95objective. A CoolSNAP HQ2 CCD camera (Photometrics, Tucson, AZ) and 
NIS-Elements AR software (Nikon) were used for image capture. For other analyses an 
Olympus BX60 microscope (U-MNU filter cube for DAPI; Omega Optical XF100-2 for 
GFP) was used with an Olympus 40xUPlanFL 40x/0.75 objective. A Cooke SenisCamQE 
camera and IPlab software (BD Biosciences Bioimaging Rockville, MD) were used for 
image capture. Images were presented using Adobe Photoshop/Illustrator. 
 For permeabilized cell in vitro nuclear import assays, the localization of FITC-GST-
TRα1 was scored as “nuclear” when there was a detectable accumulation of fluorescence 
within the nucleus. FITC-GST-TRα1 that did not accumulate in the nucleus diffused out 
into the drop of Import Buffer (see Section 2.3), since the cells were permeabilized.  Import 
assays consisted of 4 to 5 independent, biological replicates, with 200 cells scored per 
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replicate. For RNAi experiments, the localization of GFP-TRα1 was scored in one of three 
categories: completely nuclear, nuclear and cytoplasmic (with distinct accumulation in the 
nucleus), or whole cell (with no distinct nuclear accumulation).  RNAi experiments 
consisted of 3 independent, biological replicates, with 100 cells scored per replicate. To 
ensure consistency in scoring criteria, slides were randomly selected for cross-checking 
by other lab members. In all experiments, the integrity and morphology of the DAPI-
stained nuclei was assessed visually, and only cells with intact nuclei were scored. All 
cell counts were performed blind, without prior knowledge of the treatment. The slides’ 
original labels were removed and replaced with random numbers by another lab member, 
who made a key and kept it secure until scoring was completed and data were analyzed. 
For some RNAi experiments, one lab member set up the transfection and prepared slides, 
while another lab member scored the slides blind. Data were quantified as the percentage 
of cells in a given category (e.g., % of cells with a primarily nuclear distribution of TRα1) 
and presented as bar graphs. Bars indicate the mean percentage of cells in a given 
category, and error bars indicate plus or minus the standard error of the mean (± SEM). 
Statistical differences between two groups were determined using an unpaired Student’s 
t test with two-tailed P value. Results were considered significant at P<0.05. 
Luciferase reporter gene assay 
Cells were seeded at 2.0 x 104 per well in a 96-well plate (PerkinElmer, Waltham, 
MA). Seventeen hours after seeding, cells were transiently transfected with 100 ng DNA, 
containing 25 ng each of expression plasmids for GFP-TRα1, TRE (DR+4)-firefly 
luciferase reporter, Renilla luciferase internal control, scrambled shRNA control or a set 
of four target-specific shRNAs. Transfection medium was replaced with complete medium 
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8 h post-transfection. Fourteen hours post-transfection, complete medium was replaced 
with 100 µl MEM containing 10% charcoal-dextran stripped FBS (Life Technologies), 
supplemented or not with 100 nM 3,3′,5-triiodo-L-thyronine (T3, Sigma-Aldrich). After an 
additional 12 h, a Dual-Glo® Luciferase Assay (Promega) was performed, according to 
the manufacturer’s protocol, using 100 µl of reagent per well. Four independent, 
biologically separate replicate experiments were performed, with 8 wells assayed per 
treatment. Data were analyzed for statistical significance. 
GFP-Trap_A coimmunoprecipitation 
HeLa cells were seeded on 100 mm vented plates at a concentration of 9 x 105 
cells per plate in MEM supplemented with 10% FBS. Twenty-four hours post-seeding, 
each plate was transfected with expression plasmids encoding GFP, GFP-TRα1, hTERT-
GFP, GST-GFP-NLS, GFP-TRα1, GFP-GST-GFP (G3), G3-A/BD, or G3-Hinge, using 
Lipofectamine 2000. After 26 h, cells were washed with ice-cold Dulbecco’s phosphate-
buffered saline (PBS), treated for 3 min with 0.7 ml of 0.25% trypsin (Life Technologies), 
collected in 1.0 ml MEM supplemented with 10% FBS, then transferred to 2.0 ml 
microcentrifuge tubes. Cells were washed 2X with Dulbecco’s PBS, then lysed in 200 µl 
of Lysis Buffer (10 mM Tris-HCl, pH 7.2, 150 mM NaCl, 0.5 mM EDTA) containing 0.5% 
IGEPALR (NP-40 equivalent, Sigma-Aldrich) and 1X Halt Protease Inhibitor Cocktail 
(Thermo Scientific). Cells were incubated for 30 min on ice, with thorough pipetting every 
10 min. The lysate was cleared by centrifugation at 4°C, 16,000 x g for 10 min, and the 
supernatant was transferred to a new tube and diluted with 300 µl of Dilution/Washing 
Buffer (2 mM Tris-HCl, pH 7.5, 30 mM NaCl, 0.1 mM EDTA), containing 1X Halt Protease 
Inhibitor Cocktail, to yield a final concentration of 0.2% IGEPAL. GFP-trap agarose beads 
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(GFP-TrapR_A, Chromotek GmbH, Planegg-Martinsried, Germany) were pre-equilibrated 
by washing 3X with Dilution/Washing Buffer, then 20 µl were added to each diluted 
supernatant. After 2.5 h of incubation at 4°C with end-over-end rotation, beads were 
centrifuged at 4°C, 3000 x g for 4 min. A 50 µl sample of the supernatant (unbound 
proteins) was collected and resuspended with an equal volume of 2X Sample Buffer (2% 
SDS, 10% glycerol, 250 mM Tris-HCl, pH 6.8, 0.01% bromophenol blue, 20 mM DTT). 
The beads were washed 3X with 100 µl Dilution/Washing Buffer lacking IGEPAL, then 
resuspended in 100 µl of 2X Sample Buffer. Samples of unbound and bound proteins (20 
ul) were analyzed by immunoblotting (see Section 2.7), using SuperSignalTM West Femto 
Maximum Sensitivity Substrate (Thermo Scientific). Antibodies were used at the following 
concentrations: anti-GFP (Santa Cruz), 1:2000; anti-importin4 (Abcam), 1:1250; anti-
importin7 (Abcam), 1:1000; anti-importinβ1 (Santa Cruz), 1:1000; anti-importinα1 
(Abcam), 1:1000; horseradish peroxidase (HRP)-conjugated donkey anti-rabbit IgG (GE 
Healthcare Life Sciences), 1: 25,000 or 1: 33,000. 
 
Results 
TRα1 follows a signal-mediated import pathway in HeLa cells 
Our prior studies showed that TRα1 follows both signal-mediated and passive 
diffusion import pathways in Xenopus oocytes (Bunn et al., 2001). We also showed that 
there is an energy-requiring step in the nuclear retention or nuclear export process in 
mammalian cells; however, we did not address the import mechanism in mammalian 
cells. Given the specialized nature of these amphibian oocytes, it was of interest to 
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determine whether TRα1 would follow a signal-mediated import pathway in mammalian 
cells. To this end, permeabilized HeLa (human) cell in vitro nuclear import assays (Adam 
et al., 1990) were used to address this question.  
 To test whether soluble factors are required for nuclear entry of TRα1, FITC-
labeled recombinant GST-TRα1 was used for import assays in the presence or absence 
of rabbit reticulocyte lysate (RRL), as a cytosol replacement. In the presence of RRL, 
TRα1 was able to translocate into the nucleus from its starting point in the cytoplasm. 
After 30 min incubation at 30oC, on average 61% of cells showed a predominantly nuclear 
localization of TRα1. In the absence of RRL, TRα1 showed a significantly different 
localization pattern (Fig. 1, A and B; P=0.00001); the receptor did not accumulate in the 
nucleus, and formed aggregates or showed fluorescent staining of the nuclear periphery, 
an indicator of binding at the NPC without subsequent translocation (Newmeyer and 
Forbes, 1988). On average, TRα1 was only localized to the nucleus in 11% of cells.  
 Next, we sought to determine whether TRα1 import was temperature-dependent. 
Chilling has been shown to abolish active transport while only marginally affecting passive 
transport (Breeuwer and Goldfarb, 1990; Freedman and Yamamoto, 2004). However, 
given that FITC-GST-TRα1 is 73 kDa in size, this likely would preclude rapid passive 
diffusion through the NPCs regardless of temperature. Import reactions were incubated 
at 4oC for 30 min.  Nuclear import of FITC-GST-TRα1 was significantly inhibited in chilled 
cells (Fig. 1, A and B; P=0.007); on average, only 26% of cells showed nuclear 
accumulation of TRα1. Nuclear import could be fully restored, however, by further 
incubation at 30oC (P=0.584). Reversible inhibition suggests that chilling blocked TRα1 
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import by inhibiting specific transport components, rather than by preventing import by 
way of non-specific cellular damage (Bunn et al., 2001).  
 To further characterize the energy requirements for nuclear import of TRα1 in 
permeabilized HeLa cells, the effects of energy depletion were studied by apyrase 
treatment, which depletes cellular ATP and GTP (Bunn et al., 2001). Import assays were 
performed in the presence of RRL, as a cytosol replacement, and in the presence of an 
energy regeneration system or apyrase (Fig. 1, A and B). Incubation at 30oC for 30 min 
with apyrase significantly inhibited nuclear accumulation of FITC-GST-TRα1 (P=0.025). 
On average, only 40% of cells showed nuclear localization of TRα1, compared to 
reactions containing RRL and an energy regeneration system in which TRα1 was 
localized primarily to the nucleus in 61% of cells. However, TRα1 import in the presence 
of apyrase was not inhibited to the same extent as import in the absence of RRL, where 
only 11% of cells showed nuclear accumulation of TRα1. 
 Soluble factor dependence, chilling inhibition, and energy dependence are 
commonly used criteria when establishing a signal-mediated import pathway (Carazo et 
al., 2012; Dhanoya et al., 2013; Umemoto and Fujiki, 2012; Vazquez-Iglesias et al., 2009, 
2012), and thus demonstrate a requirement for signal-mediated nuclear import of TRα1 
in HeLa cells. To begin to characterize the soluble components required for nuclear 
localization of TRα1, we turned to an in vivo approach to evaluate the role of a panel of 
importins in promoting TRα1 nuclear import in HeLa cells. 
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Knockdown of importinβ1 and importin7 reduces TRα1 nuclear 
localization 
RNAi is a powerful tool for knockdown of the expression of a specific gene in vivo 
by targeting its mRNA for degradation. We chose to use importin-specific shRNA 
expression plasmids, to ensure sustained depletion of protein levels. Since TRα1 is 
primarily nuclear at steady-state, but shuttles between the nucleus and the cytosol, 
effective knockdown of an essential import factor would be predicted to result in a shift to 
a more cytoplasmic distribution of TRα1 over time. It is important to note, however, that it 
was not expected that cells would ever show a fully cytoplasmic distribution of TRα1 for 
a number of reasons. First, RNAi leaves a residual portion of target mRNA and protein in 
cells. Second, a wholly cytoplasmic distribution would depend on the complete export of 
all nuclear TRα1, which is unlikely as it is strongly retained in the nucleus by interaction 
with target genes. 
 Although the classical importinα1/β1 import pathway is widely used by nuclear 
proteins, and was thus a priority to investigate, other import pathways exist. Of particular 
interest for this study, importin7 mediates nuclear import of a diversity of cargos including 
the glucocorticoid receptor (Chook and Suel, 2011; Strom and Weis, 2001). Thus, we 
also evaluated importin7 for its role in promoting TRα1 nuclear localization. First, shRNA-
induced knockdown of importinβ1 and importin7 mRNA was validated by RT-qPCR and 
protein levels were quantified by immunoblot analysis. Twenty-six hours post-transfection 
with shRNA expression plasmids, the levels of importinβ1 and importin7 mRNA in HeLa 
cells were reduced to 21% and 19%, respectively, relative to the control shRNA (set to 
100%) (Fig. 2A). Importinβ1 and importin7 protein levels were reduced to 56% and 49%, 
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respectively, relative to the scrambled control (Fig. 2B), indicating the efficacy of the RNAi 
system. Control immunoblots also confirmed the specificity of shRNA-mediated 
knockdown of importin7, importinα1, and importinβ1; shRNA-targeting a particular 
importin did not exhibit any cross-inhibition of another importin (Fig. 2C). 
 Next, in a parallel experiment, the effect of importinα1 and importin7 knockdown 
on the cellular localization of GFP-TRα1 at 26 h post-transfection was assessed by 
fluorescence microscopy. Knockdown of importinβ1 resulted in a significant shift in 
localization of TRα1 to a more cytoplasmic distribution (P=0.002); on average only 72% 
of cells showed TRα1 primarily localized to the nucleus, compared with 86% of cells in 
the presence of control shRNA (Fig. 3, A and B).  
 Knockdown of importin7 caused a significant shift in localization of TRα1 to a more 
cytoplasmic distribution (Fig. 3, A and B; P=0.0001); on average, only 66% of cells 
showed TRα1 localized to the nucleus, with a concomitant increase in the number of cells 
with a whole cell distribution of TRα1. In addition, many of these cells were marked by 
numerous small cytoplasmic or perinuclear aggregates of TRα1. Such an accumulation 
of foci was typically not observed upon knockdown of the other importins tested. 
Interestingly, knockdown of importin7 has been shown to alter nucleolar morphology, 
resulting in a more punctate distribution of fibrillarin (Golomb et al., 2012). Taken together 
our findings suggest that both importin β1 and importin7 play key roles in promoting 
nuclear localization of TRα1 in vivo. 
Knockdown of importinα1 reduces TRα1 nuclear localization 
In an effort to further characterize additional importins playing a role in the signal- 
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mediated import pathway, the adaptor importinsα1, α3, α4, α5, and α7 were screened as 
well. Importinα6 was excluded from the analysis because its expression appears to be 
limited to the testis (Chook and Suel, 2011). These importins are known to mediate import 
in conjunction with importinβ1 in the classical nuclear import pathway. We were unable 
to achieve sufficient knockdown of the levels of importinα5 mRNA; levels only were 
reduced to 68% relative to the control shRNA with the set of four shRNA expression 
plasmids used. Thus, further analysis of this adaptor protein was not performed. In 
contrast, levels of importinα1 mRNA were knocked down to 23% of control levels, while 
levels of importinα3, α4, and α7 mRNA were knocked down to 5%, 16%, and 8%, 
respectively (Fig. 4A). Accordingly, levels of importinα1, α3, and α7 proteins were 
knocked down to 55%, 49%, and 49%, respectively, compared with the scrambled control 
(Fig. 4B). At the time this study was performed, no antibodies were available for 
importinα4, so we were only able to assess knockdown via RT-qPCR in this case. 
 Knockdown of importinα1 resulted in a significant shift of TRα1 towards a more 
cytoplasmic distribution (Fig. 4, C and D; P=0.025); on average, only 71% of cells showed 
a primarily nuclear localization of TRα1, compared to 86% of cells in the shRNA control 
(Fig. 4, C and D). There was no significant change in nuclear localization in cells depleted 
of importinα3 (P=0.190), importinα4 (P=0.425) and importinα7 (P=0.721) (Fig. 4D), 
although results with importinα7 were highly variable between replicates. These findings 
suggest that importinα1 is the main adaptor acting with importinβ1 for nuclear localization 
of TRα1.  
 We thought that dual knockdown with combinations of shRNA against importin 
β1/importinα1 or importin7/importinα1 might have a greater impact than single 
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knockdowns. However, these combinations did not result in further shifts in the 
distribution pattern of TRα1, although this could well be due to increased cell mortality. 
These importins are required for nuclear localization of many other proteins involved in 
essential cell processes. In addition, since cellular microRNAs (miRNAs) regulate the 
expression of hundreds of genes, saturation of the RNAi pathway with exogenous shRNA 
also could contribute to loss of cell viability (Castanotto and Rossi, 2009; Scherr and Eder, 
2007). Further, it is likely that the primarily nuclear location of TRα1 at steady-state limits 
how much the distribution pattern can be altered over the time course of an experiment. 
We found that extending the time course for knockdown of importins beyond 26 h post-
transfection caused a marked decrease in cell viability, in particular for importinβ1. This 
is consistent with a report that reduced levels of importinβ1 are more harmful to a cell 
than reduction in the levels of importinβ (Quensel et al., 2004). 
Nuclear import of TRα1 and TRα1 is inhibited by importazole 
To provide further evidence that importinβ1 plays a role in mediating TRα1 nuclear 
localization, we made use of importazole, a small molecule inhibitor of this pathway. 
Importazole specifically blocks importinβ1-mediated nuclear import, without disrupting 
transportin-mediated nuclear import or CRM1-mediated nuclear export (Soderholm et al., 
2011). Treatment of GFP-TRα1-expressing HeLa cells with importazole resulted in a 16% 
reduction in nuclear localization of TRα1 compared with cells treated with the vehicle 
control (P=0.000001) (Fig. 5A), providing further support for a central role of importinβ1 
in TRα1 nuclear localization. 
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The nuclear localization signal, NLS-1, in the hinge domain of TRα1 is conserved 
in the other major TR subtype, the thyroid hormone receptor β1 (TRβ1); however, NLS-2 
in the A/B domain of TRα1 is absent from TR β1 (Mavinakere et al., 2012). TR β1 typically 
has a small cytosolic population at steady-state, suggesting that its distinct distribution 
pattern may reflect an altered balance of nuclear import and nuclear export activity, 
relative to TRα1. We thus included TRβ1 in our analysis to provide a means of teasing 
apart whether importin7 and the importinβ1/α1 heterodimer interact selectively with one 
or the other NLS. Treatment of GFP-TRβ1-expressing HeLa cells with importazole 
resulted in a 12% reduction in nuclear localization of TRβ1 compared with cells treated 
with the vehicle control (P=0.001) (Fig. 5B), suggesting that importinβ1 plays a role in TR 
β1 nuclear localization, and that the interaction is mediated by the hinge domain NLS-1. 
Analysis of other import pathways 
Having shown that TRα1 localization is influenced by knockdown of importin7, 
importinα1, and importinβ1, the question still remained of whether additional pathways for 
nuclear entry are followed by TRα1. To determine whether other importins play a role in 
TRα1 nuclear localization, we screened the remainder of the well-characterized importins 
(Chook and Suel, 2011; Kimura and Imamoto, 2014). Given the structural similarity 
between importin4 and importinβ1 (Pradeepa et al., 2008), and that importin4 mediates 
import of another member of the nuclear receptor superfamily, the vitamin D receptor 
(Miyauchi et al., 2005), we predicted that importin4 might also influence TRα1 
accumulation. Many cargoes that are primarily imported by importin4 also use importin5 
as an alternative pathway (Chook and Suel, 2011). Thus, we predicted that if importin4 
was a mediator of TRα1 import, then knockdown of importin5 would have no effect on 
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TRα1 nuclear localization when importin4 was present in the cell. Importin8 is structurally 
similar to importin7 (Chook and Suel, 2011; Weinmann et al., 2009), so it was also 
conceivable that this importin could play a role in TRα1 import. In addition, importin13 has 
been shown to be one of the importins that mediates glucocorticoid receptor import (Tao 
et al., 2006), so importin13 also appeared to be a likely candidate. Importin9 imports some 
ribosomal proteins (Jakel et al., 2002) and nuclear actin (Kimura and Imamoto, 2014), 
while importin11 imports the ubiquitin-conjugating enzyme, UbcM2 (Plafker and Macara, 
2000). No role has yet been reported for these karyopherins, or for transportins1 and 2 
(Twyffels et al., 2014), in import of nuclear receptors, so they were considered less likely 
candidates. In a separate study focused on TRα1 nuclear export pathways, we confirmed 
that transportins1 and 2 are not involved in nuclear import (or export) of TRα1 
(Subramanian et al., 2015). 
 Efficacy of knockdown was assessed by immunoblotting (Fig. 6A), with levels of 
knockdown relative to the scrambled control as follows: importin4, 61%; importin5, 63%; 
importin8, 65%; importin9, 51%, importin11, 55%, and importin13, 59%. There was no 
significant change in nuclear localization of TRα1 in cells depleted of importin4 (P=0.99), 
importin5 (P=0.34), importin8 (P=0.60), importin9 (P=0.89), importin11 (P=0.55), and 13 
(P=0.70), relative to the scrambled control (Fig. 6, B and C). Taken together, these data 
indicate that importins4, 5, 8, 9, 11, and 13 either play no role in localizing TR to the 
nucleus, or are minor, nonessential mediators of nuclear localization, relative to importin7 
and the importinβ1/ α1 heterodimer.  
 Given that TRα1 is a transcription factor that either represses or stimulates 
expression of T3-responsive genes, we sought to ascertain whether the cytoplasmic shift 
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in TRα1’s distribution resulting from knockdown of importins7, α1, or β1 would reduce 
TRα1-mediated gene expression to a comparable extent. A firefly luciferase reporter gene 
under the positive control of a thyroid hormone response element (TRE) was used to 
examine ligand-dependent transactivation by GFP-TRα1 (Fig. 7), in the presence of 
shRNAs specific for importin4 (no cytoplasmic shift), importinα1, importin7, or importinβ1. 
Fold stimulation in the presence of importin-specific shRNAs was not significantly different 
compared with fold stimulation in the presence of the scrambled shRNA control (importin 
4, P=0.62; importinα1, P=0.09; importin7; P=0.24; importinβ1, P=0.27), indicating that 
under these conditions a reduction in nuclear TRα1 of 14-20% does not have a 
measurable impact on reporter gene expression. As noted earlier, these importins are 
required for nuclear localization of many other proteins involved in transcriptional 
regulation. Importin knockdown is not specific for TRα1 import and, thus, may impact 
transcriptional output in complex, unanticipated ways. 
Importin7, importinα1, and importinβ1 interact with TRα1 
Since knockdown of importin7, importinα1, and importinβ1 leads to a significant 
shift in TRα1 localization to a more cytoplasmic distribution, we sought to ascertain 
whether this shift correlates with protein-protein interactions. To confirm that these 
importins interact with TRα1 in vivo, we performed “GFP-trap” coimmunoprecipitation 
assays on lysates from HeLa cells that had been transfected with expression plasmids 
for GFP, GFP-TRα1 or GST-GFP-NLS, a fusion protein containing the classical SV40 
NLS (Lange et al., 2010; Walther et al., 2003) (Fig. 8). We confirmed that GFP, GFP-
TRα1 and GST-GFP-NLS were all successfully immunoprecipitated by the GFP-trap 
assay, by immunoblot analysis of immunoprecipitate samples with anti-GFP antibodies 
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(Fig. 8A). Samples of unbound proteins (immunosupernatant) and bound proteins 
(immunoprecipitates) were also analyzed for the presence of different importins on 
separate blots using importin-specific antibodies (Fig. 8B). Endogenous importinα1, 
importinβ1, and importin7 were coimmunoprecipitated (trapped) with GFP-TRα1, but not 
with GFP, indicating that these transport factors specifically interact with TRα1 in vivo, 
either as part of a complex (e.g., importinβ1 via the adaptor importinα1) or separately. In 
contrast, GST-GFP-NLS trapped importinα1 and importinβ1, but did not interact with 
importin7 (Fig. 6B). As a positive control for the method we also confirmed that importin7 
coimmunoprecipitated with hTERT-GFP (data not shown), as this interaction had been 
reported previously (Frohnert et al., 2014).  Finally, we used importin4 as a negative 
control, since knockdown of cellular levels of importin4 had no effect on TRα1 localization. 
As expected, importin4 was not trapped by GFP, GFP-TRα1, or GST-GFP-NLS (Fig. 8B), 
further validating the RNAi screen as a predictive tool for assessing the role of different 
importins in mediating nuclear import.  
 To examine whether importin7 and the importinβ1/ α1 heterodimer interact 
selectively with NLS-1 (hinge domain) or NLS-2 (A/B domain) in TRα1, we used two 
different approaches. First, we investigated whether TRα1, which only contains NLS-1, 
interacts with these importins, using the GFP-trap assay. Samples of unbound proteins 
(immunosupernatant) from GFP-TRα1-expressing HeLa cell lysates and bound proteins 
(immunoprecipitates) were analyzed for the presence of “trapped” importins by 
immunoblotting using importin-specific antibodies (Fig. 8C). Endogenous importinβ1 and 
the adaptor importinα1 were coimmunoprecipitated with GFP-TRα1, but not with GFP (in 
some assays there was a trace amount of non-specific trapping of importins by GFP), 
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indicating that these transport factors specifically interact with TRα1 in vivo. In contrast, 
importin7 did not show interaction above background levels with GFP-TRα1 (Fig. 8C). 
 In a second approach, we investigated whether the TRα1 hinge domain or the A/B 
domain alone, fused with GFP-GST-GFP (G3) interacted with these importins. We have 
previously shown that G3-Hinge has a predominantly nuclear localization, comparable to 
full-length TRα1, whereas only around 50% of cells show a predominantly nuclear 
localization of G3-A/BD (Mavinakere et al., 2012), indicating that NLS-2 is less efficient in 
facilitating nuclear import in isolation. HeLa cells were transfected with expression 
plasmids for G3, G3-Hinge, or G3-A/BD and immunoprecipitated by the GFP-trap assay. 
Samples of unbound proteins and bound proteins were analyzed for the presence of G3 
fusion proteins with GFP-specific antibodies (data not shown), and with the different 
importins on separate blots using importin-specific antibodies (Fig. 8D). Endogenous 
importinα1 and importinβ1 were coimmunoprecipitated (trapped) with both G3-Hinge and 
G3-A/BD, indicating that these transport factors specifically interact with NLS-1 and NLS-
2 in vivo. In contrast, no consistent interaction above background levels was observed 
between importin7 and G3-Hinge or G3-A/BD (Fig. 8D). 
 Taken together, we conclude from these results that TRα1 nuclear import is 
facilitated by importin7, likely through interactions with NLS-2, and importinβ1 and the 
adapter importin α1 interacting with NLS-1 and NLS-2, while TRβ1 nuclear import is 
facilitated by importinβ1/ α1 interacting with NLS-1. Further studies with purified 
recombinant proteins in vitro will be required to confirm this model, since we were not 
able to show direct interaction between importin 7 and NLS-2 in this study. When taken 
79 
 
out of the context of the full protein, the A/B domain NLS-2 may not be exposed in a way 
that promotes stable binding under the conditions of the GFP-trap assay. 
 
Discussion 
Our interest for many years has been in the complex mechanisms regulating the 
subcellular distribution of TRα1. The emerging picture is one of a finely balanced, dynamic 
process in which TRα1 shuttles between the nucleus and cytoplasm. Here, we have 
further investigated the pathway by which TRα1 enters the nucleus, using in vitro nuclear 
import assays, importin-specific shRNAs and a small molecule inhibitor of importinβ1, in 
combination with localization assays in transfected cells and coimmunoprecipitation 
assays to confirm interacting partners. The results of this research show that TRα1 can 
enter the nucleus by more than one pathway; both IPO7 and the classical IPOβ1/α1 
heterodimer mediate TRα1 nuclear import. 
 The use of more than one pathway by individual cargos is not without precedent. 
A striking example is the human immunodeficiency virus type 1 Rev protein which binds 
specifically to importinβ1, transportin1, importin5, and importin7 (Arnold et al., 2006). 
Importin7 is a notably versatile karyopherin and often plays a shared role with other 
karypherin-β family members in importing cargo, ranging from ribosomal proteins (Jakel 
and Gorlich, 1998) and histones (Baake et al., 2001; Muhlhausser et al., 2001) to 
transcription factors, such as c-Jun (Waldmann et al., 2007) and Smad3 (Chuderland et 
al., 2008). Adding to its versatility, importin7 can mediate import either as a monomer or 
as an importin7/importinβ1 heterodimer (Chook and Suel, 2011).  
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 There is ample evidence that other members of the nuclear receptor superfamily 
are imported via multiple pathways. For example, the glucocorticoid receptor (GR) 
contains two NLSs, NL1 and NL2, each of which has been shown by in vitro binding 
assays to interact directly with importin7 and importin8, but only NLS1 was able to bind 
the importinβ/α heterodimer. Further, only importin7 and the importinβ/α heterodimer 
were able to import an NL1-containing fragment of GR in an in vitro import assay 
(Freedman and Yamamoto, 2004). In addition, GST pull-down and 
coimmunoprecipitation assays have shown that importin13 also binds GR, and silencing 
of importin13 by RNAi inhibits nuclear import of GR (Tao et al., 2006). The androgen 
receptor also contains two NLSs and import is mediated via two pathways: one that is 
dependent on importinα1/β1, and one that is importinα1/β1-independent (Cutress et al., 
2008; Kaku et al., 2008).  
 The six identified mammalian importin α adaptors are ubiquitously expressed, with 
the exception of testis-specific importinα6 (Kelley et al., 2010; Kohler et al., 1999). 
Although interchangeable for many substrates in vitro, there are reports of preferential 
use of specific importinα adapters in vivo; for example, for NF-B (Fagerlund et al., 2005), 
STAT3 (Liu et al., 2005), the Ran guanine nucleotide exchange factor, RCC1 (Friedrich 
et al., 2006; Quensel et al., 2004), and STAT5a (Shin and Reich, 2013). Our findings 
suggest that only importinα1 plays a key role in mediating import of TRα1, adding to the 
preferential use of this adaptor in vivo. 
 The critical role of nuclear import as a control point for modulating thyroid hormone-
responsive gene expression is apparent, but the physiological significance of multiple 
import pathways remains to be determined. Our prior studies have shown that the hinge 
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region of TRα1 contains NLS-1, a classical, bipartite NLS 
(130KRVAKRKLIEQNRERRRK147; Mavinakere et al., 2012). Data presented here indicate 
that import from this classical NLS is mediated by importinsα1 andβ1 acting together. 
TRα1 also harbors a second, non-classical NLS, NLS-2, in the N-terminal A/B domain 
(22PDGKRKRK29; Mavinakere et al., 2012). TR α1 only harbors NLS-1 (Mavinakere et al., 
2012) and, as shown here, does not interact with importin7.  By default, this suggests that 
the novel monopartite NLS-1 in TRα1 provides the signal for use of an alternative pathway 
for nuclear entry facilitated by importin7, at a different time, or in a cooperative fashion 
with the classical NLS to enable complete, efficient TRα1 import. Additional analyses of 
protein-protein interactions by in vitro binding assays with purified proteins should help to 
identify and clarify whether this NLS interacts directly with an importin7 monomer, or 
potentially with an importin7/importin β1 heterodimer, and will allow fuller elucidation of 
how multiple pathways serve to regulate nuclear entry in response to cell-specific signals. 
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Fig. 1. In vitro nuclear import of TR1 requires soluble factors and is temperature and energy-dependent. 
(A) Digitonin-permeabilized HeLa cells were incubated with import reaction mix containing FITC-GST-
TR1 as substrate, under the conditions indicated: 30ºC or 4ºC followed by 30ºC, with an energy 
regeneration system or apyrase, and in the presence or absence of rabbit reticulocyte lysate (RRL) as a 
source of replacement cytosol. After 30 min, samples were fixed, mounted, and viewed by fluorescence 
microscopy. In the presence of RRL, TR1 was localized to the nucleus. In the absence of RRL, and in 
chilled or energy-depleted cells, TR1 did not accumulate in the nucleus. Scale bar = 10 m. (B) 
Quantification of TR1 nuclear localization. Bars indicate the mean percentage of cells with nuclear 
accumulation of TR1 (n=4-5 independent, biologically separate replicate experiments, with 200 cells per 
replicate) and error bars indicate  SEM. ***P<0.001; **P<0.01; *P<0.05. 
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Fig. 2. RNAi specifically knocks down selected importins. (A) HeLa cells were transfected with importin-
specific shRNA plasmids or a scrambled shRNA plasmid as a control, as indicated. RT-qPCR was used to 
confirm knockdown of importin mRNA levels. Bars indicate the mean relative expression level of importin 
mRNA in cells treated with importin-specific shRNA versus control cells, normalized to the levels of the 
housekeeping mRNA GAPDH. Error bars indicate ±SEM (n=3 independent, biologically separate 
replicates). (B) Immunoblot analysis was used to confirm knockdown of importin protein levels, as 
indicated. Bars indicate the mean relative expression level of importin proteins in cells treated with 
importin-specific shRNA (knockdown) relative to cells treated with the scrambled shRNA control, 
normalized to levels of GAPDH. Error bars indicate ±SEM (n=3 independent, biologically separate 
replicates). (C) Knockdown is specific for the selected importin. Immunoblot analysis was used to confirm 
that knockdown of a target importin with a specific shRNA, as indicated, did not have an effect on 
expression levels of other importins. 
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Fig. 3.  Knockdown of importin 1 (Imp 1) and importin 7 (Ipo 7) by RNAi reduces nuclear accumulation 
of TR1. (A) HeLa cells cotransfected with shRNA and GFP-TR1 expression plasmids, as indicated, were 
analyzed by fluorescence microscopy after staining with DAPI to visualize the nucleus. Scale bar = 10 m. 
(B) HeLa cells cotransfected with shRNA and GFP-TR1 expression plasmids were fixed and scored for 
TR1 localization: N, completely nuclear; N+C, nuclear and cytoplasmic (with distinct nucleus); WC, 
whole cell (nucleus not distinct). Bars indicate the mean percentage of cells in a given category (n=3 
independent, biologically separate replicate experiments, with 100 cells per replicate), and error bars 
indicate  SEM. ***P<0.001; **P<0.01. 
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Fig. 4. Knockdown of importin 1 (Imp 1) by RNAi reduces nuclear accumulation of TR1. HeLa cells 
were transfected with importin-specific shRNA plasmids or a scrambled shRNA plasmid as a control, as 
indicated. RT-qPCR (A) and immunoblots (B) were used to confirm knockdown of importin mRNA and 
protein levels, respectively. Error bars indicate  SEM (n=3 independent, biologically separate replicates). 
(C) HeLa cells cotransfected with shRNA and GFP-TR1 expression plasmids, as indicated, were analyzed 
by fluorescence microscopy. Scale bar = 10 m. (D) HeLa cells cotransfected with shRNA and GFP-TR1 
expression plasmids were scored for TR1 localization: N, completely nuclear; N+C, nuclear and 
cytoplasmic (with distinct nucleus); WC, whole cell (nucleus not distinct). Bars indicate the mean 
percentage of cells in a given category (n=3 independent, biologically separate replicate experiments, with 
100 cells per replicate), and error bars indicate  SEM.  *P<0.05. 
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Fig. 5. Importazole reduces nuclear localization of TR1 and TR1. HeLa cells were transfected with GFP-
TR1 (A) or GFP-TR1 (B) expression plasmids and untreated, treated with vehicle, or treated for 5 h with 
50 M importazole, a small molecule inhibitor of importin 1. Cells were then fixed and scored for 
localization of TR1 or TR1: N, completely nuclear; N+C, nuclear and cytoplasmic (with distinct 
nucleus); WC, whole cell (nucleus not distinct). Bars indicate the mean percentage of cells in a given 
category (n=3 independent, biologically separate replicate experiments, with 200 to 400 cells per replicate), 
and error bars indicate  SEM. ***P<0.001. 
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Fig. 6. Knockdown of importins 4, 5, 8, 9, 11, and 13 has no effect on nuclear accumulation of TR1. (A)  
HeLa cells were transfected with importin (Ipo)-specific shRNA plasmids or a scrambled shRNA plasmid 
as a control, as indicated, and immunoblot analysis was used to confirm knockdown of importin protein 
levels. Error bars indicate  SEM (n=3 independent, biologically separate replicates). (B) HeLa cells 
cotransfected with shRNA and GFP-TR1 expression plasmids, as indicated, were analyzed by 
fluorescence microscopy after staining with DAPI to visualize the nucleus. Scale bar = 10 m. (C) HeLa 
cells cotransfected with shRNA and GFP-TR1 expression plasmids, as indicated, were scored for TR1 
localization: N, completely nuclear; N+C, nuclear and cytoplasmic (with distinct nucleus); WC, whole cell 
(nucleus not distinct). Bars indicate the mean percentage of cells in a given category (n=3 independent, 
biologically separate replicate experiments, with 100 cells per replicate), and error bars indicate  SEM. 
P>0.05. 
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(B) Immunosupernatants (Unbound) and immunoprecipitates (Bound) from GFP, GFP-TR1, and GST-
GFP-NLS-expressing cell lysates were analyzed on separate immunoblots (using longer exposure times for 
the immunoprecipitates), with importin-specific antibodies to detect importin 4 (119 kDa), importin 1 (58 
kDa), importin 1 (97 kDa), and importin 7 (119 kDa), as indicated. The identity of the ~55 kDa band on 
the importin 1 immunoblot trapped by GST-GFP-NLS is not known.  
 
 
Fig. 7. Knockdown of importins 4, 1, 7, 
and 1 does not significantly alter TR1-
mediated gene expression. HeLa cells were 
cotransfected with expression plasmids for 
GFP-TRα1, TRE (DR+4)-firefly luciferase 
reporter, Renilla luciferase internal control, 
and scrambled shRNA control or a set of 
four target-specific shRNAs, as indicated. 
Data are presented as fold stimulation in the 
presence of T3, relative to luciferase 
activity (firefly/Renilla) in the absence of 
T3. Error bars indicate  SEM (n=4 
replicates of 8 wells per treatment). P>0.05. 
 
Fig. 8. Importin 1, importin 1, and 
importin 7 coimmunoprecipitate with 
TR1. HeLa cells were transfected with 
expression plasmids encoding GFP (27 
kDa), GFP-TR1 (73 kDa), GST-GFP-NLS 
(54 kDa), GFP-TR1 (79 kDa), GFP-GST-
GFP (G3) (80 kDa), G3-A/BD (containing 
NLS-2) (86 kDa), or G3-Hinge (containing 
NLS-1) (87 kDa), as indicated. Cell lysates 
were subjected to coimmunoprecipitation 
using immobilized anti-GFP-antibodies 
(GFP-Trap_A). Representative 
immunoblots are shown (n=3-5 
independent, biologically separate replicate 
experiments). Protein size was verified 
using Pre-Stained Kaleidoscope Protein 
Standards. (A) Trapped GFP-tagged 
proteins were analyzed by immunoblotting 
with antibodies specific for GFP. The two 
lower molecular weight bands in the GFP-
TR1 lane represent specific degradation 
products. 
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Fig. 8. (C) Immunosupernatants (Unbound) and immunoprecipitates (Bound) from GFP and GFP-TR1-
expressing cell lysates were analyzed by immunoblotting, with importin-specific antibodies, as indicated. 
(D) Immunosupernatants (Unbound) and immunoprecipitates (Bound) from G3-A/BD and GFP-Hinge-
expressing cell lysates were analyzed by immunoblotting, with importin-specific antibodies, as indicated. 
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Chapter 4: Discussion and Future Directions 
 
Importins are essential factor in the transports activity of NLS-containing cargo 
proteins. Although many importins used by NLS-containing proteins have been identified, 
prior to this thesis research, the question still remained of how many different import 
pathways are used by TR. Here, we have demonstrated that TRα1 not only uses the 
classical import pathway directed by IPOβ1/α1 heterodimer but it also uses an IPO7 
mediated import pathway. Since our published paper acknowledged the possibility that 
other importins, whose knockdown didn’t effect TRα1 nuclear localization, might still have 
minor roles in transporting TRα1 into the nucleus, testing their physical interactions with 
TRα1 using GFP-trap might exclude any doubt.  
Another questionable result that needs to be confirmed in the future is the NLS 
that binds with IPO7. Although performing a IPO7-IPOβ1 double knockdown is unlikely to 
be achievable, even with a less toxic transfection method, an experiment to observe the 
impact of removing this heterodimer on TRα1 localization could be very valuable. One 
way to determine if a cargo is transported either by the IPO7-IPOβ1 heterodimer or 
individual importins is to measure the cargo’s transport rate under conditions in which 
both are present, both absent, and each individual IPO is present. When a cargo’s nuclear 
import occurs only in the presence of both IPO7 and IPOβ1, it is likely that this cargo is 
strictly transported by the IPO7-IPOβ1 heterodimer. Wohlwend et al. (2007) used 
thermodynamic analysis of H1 transport to identify the binding sites on H1 for both IPO7 
and IPOβ1. Furthermore, positive cooperation between these two karyopherins in binding 
H1 was also revealed, indicating that H1 is imported by the heterodimer. In contrast, when 
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a cargo’s import occurs in the presence of one of the two importins but the binding is 
significantly enhanced by introducing the other importin, it is likely that the cargo’s 
transport is preferably mediated by the heterodimer but individual importins are still 
capable of doing so. Wodrich and colleagues (2006) reported that the import rate of pVII 
is increased when both karyopherins are expressed, which puts pVII in the group of 
cargos that preferably utilize the heterodimer for nuclear import. Finally, when a cargo’s 
transport is not enhanced in the presence of both importins, it can be concluded that the 
cargo is imported by the importins individually.  
On the other hand, many lab members have been working on post-translational 
modification of TRα1. Knowing how ubiquitination, acetylation, phosphorylation (Nicoll et 
al., 2003), and sumoylation manipulate TRα1 localization will help to explain the 
regulation of this in vivo transport mechanism. The work conducted by the Allison lab has 
helped to elucidate TR’s nucleocytoplasmic transport. Studying this transport cycle also 
helps in the understanding of the genetic regulatory mechanisms of TR, in addition to 
understanding the activity of other members of the nuclear receptor superfamily.  
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Chapter 5: Additional Work 
The following chapter includes additional work done by the candidate. Data sheets 
1-3 show the “trapping” results of replicate experiments with IPOα1, IPOβ1, and IPO7 
that also included a positive control for IPO7 interaction, telomerase reverse transcriptase 
(Tert). This positive control was not included in the published manuscript, because we 
also found that Tert interacted with IPOβ1, which contradicted the results reported as 
“data not shown” by the researchers that we obtained the expression vector from. Data 
sheets 4-7 were collected from the work done for exportin (XPO4, XPO5, XPO6, and 
XPO7) coimmunoprecipitation with GFP-TRα1. Data show significant protein-protein 
interactions between TRα1 and XPO4, XPO5, and XPO7, but not XPO6. 
 
Introduction 
As mentioned in the General Introduction (Chapter 1), karyopherins that are in 
charge of importing cargo into the nucleus are called importins, whereas those that are in 
charge of exporting cargo back to the cytoplasm are exportins. Since this thesis mainly 
focused on the study of importin pathways, exportins were only addressed briefly in the 
General Introduction. A more detailed introduction to exportins in general, and those that 
are involved in TR nuclear export is provided in this final chapter.  
Just like how the gradient of nucleotide-bound Ran influences cargos binding to 
importins, exportin cargo affinity also depends on the RanGTP/RanGDP ratio. However, 
in contrast to importins, exportins form stable export complexes with their cargos in the 
nucleus with a high concentration of RanGTP, whereas their affinity gets lower in a high 
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concentration of RanGDP. Export complexes, composed of exportin, RanGTP, and cargo 
dissociate in the cytoplasm by interacting with RanGAP when they pass through the NPC 
(Lee et al., 2011). The process of cargo export is illustrated in Figure 5 (see Chapter 1). 
Recall that cargo import is determined by the recognition of NLSs; likewise, exportins bind 
with specific nuclear export signals (NESs). Among the 20 karyopherins, at least 7 of 
them in human cells are exportins (Fung and Chook, 2014): CRM1, CAS, exportin-t, 
exportin 4, exportin 5, exportin 6 and exportin 7.  
Although many reports in the literature assert that their cargos of interest utilize a 
CRM1 (exportin1)-dependent export pathway, due to the fact that CRM1 is the most 
studied and well characterized exportin, it is still possible that those proteins of interest 
also might have an unanticipated dependency on other exportin pathways. Indeed, just 
like how most proteins require more than one importin for efficient transport, exportin 
pathways are usually shared amongst export cargos. For example, small nuclear RNAs 
are exported using both exportin 5 and CRM1 (Lee et al., 2011). As for our research on 
TRα1 nucleocytoplasmic transport, the paper published in 2008 by Grespin and 
colleagues provided evidence of how TRα1 can utilize a CRM1/calreticulin-dependent 
export mechanism. Meanwhile, Subramanian et al.’s work in 2015 suggested that TRα1 
export is also influenced by exportin 4 (XPO4), exportin 5 (XPO5), and exportin 7 (XPO7). 
It was not entirely unexpected that an essential hormone receptor like TRα1, which uses 
multiple importins to enter the nucleus, also would require multiple exportins to get back 
to the cytoplasm. In this chapter, exportins that are involved in TRα1 nuclear export will 
be examined.  
CRM1, also known as XPO1, was the first exportin discovered in 1989. It was given 
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the name “Chromosomal Region Maintenance” due to its impact on chromosome 
structure (Adachi and Yanagida, 1989). In 1997, researchers identified CRM1’s essential 
role in exporting molecules (Fornerod et al., 1997). Using its natural inhibitor leptomycin 
B (LMB) to study the pathway, CRM1 has been shown to facilitate the most diverse, yet 
specific, export pathway (Xu, et al., 2012). Although CRM1 mostly interacts with 
hydrophobic leucine-rich-NESs (Kosugi et al., 2008), some nuclear receptors, such as 
TRα1 that have NESs that diverge from this consensus, could still use this export 
pathway. Up to now, over 300 different cargos have been identified to be exported by 
CRM1, including several tumor suppressors, cell growth regulators and vitamin receptors 
(Shen et al., 2009). Overexpression of CRM1 has been confirmed to be a contributing 
factor in certain diseases such as ovarian cancer (Noske et al., 2008). Meanwhile, CRM1 
inhibition has also been shown recently to lead to apoptosis of certain cancer cells by 
restoring tumor suppressor localization and function (Kojima et al., 2013).  The 
architecture of CRM1 appears to be relatively conserved across different organisms 
(Berman et al., 2000). The molecular weight of CRM1 is about 120 KDa which is similar 
to other exportins. CRM1’s full length structure, which contains 21 HEAT repeats, was 
reported in 2009. Each of the 21 HEAT repeats has specific functions and the cooperation 
between these repeats directly alters CRM1 activity. When CRM1 interacts with a cargo 
protein, it adapts its structure to a closed ring shape by connecting the N-terminal HEAT 
repeats and C-terminal HEAT repeats (Dong et al., 2009). HEAT repeats 11 and 12 form 
a hydrophobic groove on the surface of CRM1 to bind NESs. Other HEAT repeats, such 
as 8, 9 and 10 may also contribute to mediating CRM1’s conformation which is crucial for 
its function (Monecke et al., 2009). 
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Some exportins are overshadowed by CRM1’s influential “reputation.” In the early 
days, CRM1 was assumed to be the carrier of most proteins. But after more exportins 
were discovered and more research was conducted into the role played by each exportin, 
scientists found out that credit was given to CRM1 when, in fact, it is not responsible for 
exporting certain cargos. A perfect example is the cytosolic-localized protein actin. Until 
2003, scientists believed that it was CRM1 that exports actin to the cytoplasm and 
maintains this distribution (Wada et al., 1998). However, it was later reported that CRM1 
does not interact with actin directly. XPO6, instead, is considered as the major transporter 
for actin (Stüven et al., 2003). XPO6 is conserved from amoeba to vertebrates. To date, 
actin and actin-profilin complexes are the only identified cargos that use the XPO6 
pathway (Park et al., 2011). In this thesis research, XPO6 was used as a negative control. 
 According to Lipowsky et al.’s 2000 research paper, XPO4 does not show obvious 
orthologues in yeast but seems to be conserved amongst eukaryotes. At that time, the 
only confirmed cargo of XPO4 was eukaryotic translation initiation factor 5A (eIF-5A). eIF-
5A’s affinity for XPO4 is at least 1000 times higher than for CRM1, exportin-t, or CAS, 
indicating its binding specificity. Since 2000, more XPO4 cargos have been discovered. 
In 2006, Smad3 became the second identified export cargo of XPO4 by Kurisaki and his 
colleagues. Interestingly, besides exporting Sox9 protein, many studies suggests that 
XPO4 also imports certain Sox family proteins, such as Sox2 and SRY, into the nucleus 
in a Ran-independent manner (Gontan et al., 2009). Furthermore, XPO4 is also described 
as a tumor suppressor gene of hepatocellular carcinoma (HCC), due to the fact that 
hepatitis B virus (the major cause of HCC) infected patients show a dramatic decrease in 
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expression of XPO4 (Zhang et al., 2014). XPO4’s cargo pool is continuously being 
extended. 
 Generally speaking, certain proteins and small double-stranded RNAs like 
microRNAs are exported by XPO5 (Lee et al., 2011). However, before interacting with 
any cargo, XPO5 needs to bind RanGTP in the nucleus first. This XPO5-RanGTP 
complex forms a baseball mitt-like structure to pack the cargo into the inner surface 
(Okada et al., 2009). Although the physical interaction between XPO5-RanGTP complex 
and double-stranded RNAs is usually weak, the mitt-like structure acts as a “shield” to not 
only retain the cargo but also protect it from ribonuclease digestion. The protecting role 
of XPO5 does not end until the complex locates in the cytoplasm and encounters the 
enzyme Dicer, meaning that XPO5 perhaps is able to resist RanGAP-mediated cargo 
release. Therefore, XPO5 is also viewed as a double-stranded RNA stabilizer, which is 
similar to the protein chaperone activity of IPOβ1. Like CRM1, XPO5 also has 21 HEAT 
repeats and each one of them influences XPO5’s function by altering its conformation. 
Although XPO5 is known for specifically exporting double-stranded pre-RNAs, it has also 
been confirmed that proteins such as androgen receptor use XPO5 as their transporters. 
 XPO7, also known as RanBP16, actively exports numerous proteins including 14-
3-3σ and p50RhoGAP to the cytoplasm (Mingot et al., 2004). However, like XPO6, both 
XPO7 substrates were suggested to be exported by CRM1 at first (Brunet et al., 2002). 
Due to its diverse cargo pool, the XPO7 pathway was defined as the second general 
export pathway besides the CRM1 pathway. Compared to CRM1, whose cargos appear 
to share a common leucine-rich NES, XPO7’s cargos don’t have any structural or 
functional similarity. Interestingly, Brunet and colleagues discovered that XPO7 interacts 
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with 14-3-3σ through a highly charged motif composed of clusters of basic residues. The 
same result was observed for p50RhoGAP. In both cases, basic residue clusters seem 
to be important for cargo recognition by XPO7. 
 
Methods 
 The work published by Grespin et al. (2008) demonstrated that CRM1 interacts 
directly with TRα1 and mediates nuclear export in a cooperative manner with calreticulin. 
Subramanian and colleagues in 2015 then went on to demonstrate that XPO4, XPO5, 
and XPO7 also influence TRα1 localization, suggesting these exportins are additional 
candidates for exporting TRα1 back to the cytoplasm through a CRM1-independent 
pathway. Knocking down any one of these exportins resulted in increased TRα1 nuclear 
retention and a decrease in nucleocytoplasmic shuttling, whereas overexpression lead to 
an increased TRα1 cytoplasmic localization pattern. However, without the proof of direct 
protein-protein interaction, the candidacy of XPO4, XPO5, and XPO7 was only a 
suggestion. Data sheets 4-7 provided in the next section show western blotting results 
after coimmunoprecipitation assays for XPO4, XPO5, XPO6 and XPO7. The techniques 
used are described in detail in Chapter 2 (Materials and Methods). On the data sheets, 
key information is provided, including primary and secondary antibody dilution, X-ray film 
exposure time, target protein concentration, target protein size, and number of replicates. 
“Trapping result” indicates proteins that were coimmunoprecipitated or “trapped”, 
whereas “unbound result” shows proteins that were left in the supernatant.  
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Results 
Data Sheet 1. IPOα1 coimmunoprecipitation result using Tert-GFP as 
a positive control 
       
     IPOα1 trapping result                  IPOα1 unbound result 
 
                   
 
 
                               
Primary antibody    1:1000, rabbit polyclonal (Abcam) 
Secondary antibody    1:33000, anti-rabbit IgG from donkey (GE Healthcare Life Sciences) 
Trapping result 
exposure time 
   10 sec 
Unbound result 
exposure time 
   1 sec 
Replicates    4 
Sample loading volume    20µl/each wall 
IPOα1 size    58 kDa 
Data sheet 1: IPOα1 coimmunoprecipitation result using Tert-GFP as a positive 
control: As the blot shows, Tert-GFP interacts with IPOα1 directly. This information was 
not included in the publication. 
99 
 
Data Sheet 2. IPOβ1 coimmunoprecipitation result using Tert-GFP as 
a positive control 
 
               IPOβ1 trapping result              IPOβ1 unbound result 
 
                   
 
 
                           
Primary antibody    1:1000, rabbit polyclonal (Santa Cruz) 
Secondary antibody    1:25000, anti-rabbit IgG from donkey (GE Healthcare Life Sciences) 
Trapping result 
exposure time 
   2 min 
Unbound result 
exposure time 
   5 sec 
Replicates    4 
Sample loading volume    20µl/each wall 
IPOβ1 size   90 kDa 
Data sheet 2: IPOβ1 coimmunoprecipitation result using Tert-GFP as a positive 
control: As the western blot shows, Tert-GFP also interacts with IPOβ1. Since the result 
does not agree with what the laboratory that provided us with the protein expression 
plasmid had published (as data not shown), it was not included in our publication.  
100 
 
Data Sheet 3. IPO7 coimmunoprecipitation result using Tert-GFP as a 
positive control 
  IPO7 trapping result         IPO7 unbound result 
 
                   
 
 
                                  
  
Primary antibody    1:1000, rabbit polyclonal (Abcam) 
Secondary antibody    1:25000, anti-rabbit IgG from donkey (GE Healthcare Life Sciences) 
Trapping result 
exposure time 
   2 min 
Unbound result 
exposure time 
   10 sec 
Replicates    5 
Sample loading volume    20µl/each wall 
IPO-7 size    120 kDa 
Data sheet 3: IPO7 coimmunoprecipitation result using Tert-GFP as a positive 
control: Western blot shows that Tert-GFP interacts with IPO7 directly. Although these 
data were not included in our publication, their accuracy was confirmed by the laboratory 
that provided us with Tert-GFP. 
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Data Sheet 4. XPO4 coimmunoprecipitation result 
   
XPO4 trapping result                              XPO4 unbound result 
 
                   
 
 
                                  
  
Primary antibody    1:500, rabbit monoclonal (Abcam) 
Secondary antibody    1:25000, anti-rabbit IgG from donkey (GE Healthcare Life Sciences) 
Trapping result 
exposure time 
   2 min 
Unbound result 
exposure time 
   10 sec 
Replicates    5 
Sample loading volume    20µl/each wall 
XPO4 size    127 kDa 
 
Data Sheet 4. XPO4 coimmunoprecipitation result: Three replicates of GFP-TRα1 
were loaded on the same gel. From the “unbound result”, the presence of eGFP or GFP-
TRα1 was confirmed. The “trapping result” shows a clear interaction between XPO4 and 
GFP-TRα1. 
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Data Sheet 5. XPO5 coimmunoprecipitation result 
 
               XPO5 trapping result        XPO5 unbound result 
 
                   
 
 
                                  
  
Primary antibody    1:2000, rabbit polyclonal (Abcam) 
Secondary antibody    1:25000, anti-rabbit IgG from donkey (GE Healthcare Life Sciences) 
Trapping result 
exposure time 
   10 sec 
Unbound result 
exposure time 
   1 sec 
Replicates   8 
Sample loading volume    20µl/each wall 
XPO5 size    136 kDa 
 
Data Sheet 5. XPO5 coimmunoprecipitation result: One replicate of GFP-TRα1 was 
loaded on the gel. From the “unbound result”, the presence of eGFP or GFP-TRα1 was 
confirmed. The “trapping result” shows a clear interaction between XPO5 and GFP-TRα1. 
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Data Sheet 6. XPO6 coimmunoprecipitation result 
 
XPO6 trapping result        XPO6 unbound result 
 
                   
 
 
                                  
 
  
Primary antibody    1:1000, rabbit polyclonal (Abcam) 
Secondary antibody    1:25000, anti-rabbit IgG from donkey (GE Healthcare Life Sciences) 
Trapping result 
exposure time 
   2 min 
Unbound result 
exposure time 
   2 min 
Replicates    6 
Sample loading volume    20µl/each wall 
XPO6 size    129 kDa 
 
Data Sheet 6. XPO6 coimmunoprecipitation result: One replicate of GFP-TRα1 was 
loaded on the gel. From the “unbound result”, the presence of eGFP or GFP-TRα1 was 
confirmed. The “trapping result” shows no interaction between XPO6 and GFP-TRα1. 
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Data Sheet 7. XPO7 coimmunoprecipitation result 
 
XPO7 trapping result            XPO7 unbound result 
 
                   
 
 
                                                         
  
Primary antibody    1:1000, goat polyclonal (Abcam) 
Secondary antibody    1:25000, anti-goat IgG from mouse (Santa Cruz) 
Trapping result 
exposure time 
   1 min 
Unbound result 
exposure time 
   10 sec 
Replicates    8 
Sample loading volume    20µl/each wall 
XPO7 size    110 kDa 
 
Data Sheet 7. XPO7 coimmunoprecipitation result: One replicate of GFP-TRα1 was 
loaded on the gel. From the “unbound result”, the presence of eGFP or GFP-TRα1 was 
confirmed. The “trapping result” shows a clear interaction between XPO7 and GFP-TRα1. 
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Conclusion 
 Years of effort have been dedicated to mapping the cycle of the dynamic and 
precisely balanced process of TRα1 nucleocytoplasmic transport. Previous chapters of 
this thesis discussed the importins that are involved in TRα1 nuclear import. In this final 
chapter, potential exportins that were believed to influence TRα1 cytoplasmic localization 
were further investigated by using coimmunoprecipitation assays and western blot 
analyses. The results presented here confirm that XPO4, XPO5 and XPO7 have direct 
protein-protein interactions with TRα1, meaning that besides CRM1, TRα1 also uses 
XPO4, XPO5 and XPO7 pathways to translocate back to the cytoplasm. As a negative 
control, XPO6 was also tested along with the other exportins and the results indicate no 
interaction between TRα1 and XPO6. To date, all karyopherins that mediate TRα1 
nucleocytoplasmic shuttling have been identified. The IPOβ1/α1 complex and IPO7 are 
the main importins that carry TRα1 into the nucleus, whereas CRM1, XPO4, XPO5, and 
XPO7 are the exportins that transport TRα1 back to the cytoplasm. The question of which 
importin recognizes which TRα1 NLS was addressed in the publication included in this 
thesis (Roggero et al., 2016); however, the same question remains to be answered for 
the exportins. So far, we know that TRα1 has three CRM1-independent NESs located in 
the ligand binding domain. The next step will be to test which exportins interact directly 
with each of these NESs in TRα1. 
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